Female genital neoplasms

Guidelines, reviews, epidemiology

Cervical cancer

• Africa
  • BMC Women's Health
    • Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective [2016]
  • WHO African Region
    • WHO AFRO Investment Case Series: Accelerating Cervical Cancer Elimination in Africa through Strengthened HPV Vaccination, Screening and Treatment [2024]
    • Framework for the implementation of the global strategy to accelerate the elimination of cervical cancer as a public health problem in the WHO African Region: report of the Secretariat [2021]
    • Strategic planning for cervical cancer prevention and control in Africa: training manual – facilitator manual [2017]
    • Strategic Planning for Cervical Cancer Prevention and Control in Africa: Training Manual - Participants Manual [2017]
    • Information, education and communication for cervical cancer prevention and control in African countries: Training Guide [2017]
    • Assessing Country Capacity and Preparedness for Introducing or Scaling up a Comprehensive Cervical Cancer Prevention and Control Programme: Baseline Report, , December 2014 [2017]
    • Advocacy for cervical cancer prevention and control in Africa: facilitator manual [2017]
    • Cervical cancer
• Americas
  • Pan American Health Organization
    • Plan of Action for Cervical Cancer Prevention and Control 2018-2030 [2018]
    • Cervical Cancer
    • A Global Strategy for elimination of cervical cancer
• Antigua and Barbuda
  • International Journal of Environmental Research and Public Health
    • Cost Analysis Related to Diagnosis, Treatment and Management of Cervical Cancer in Antigua and Barbuda: A Prevalence-Based Cost-of-Illness Study [2024]
• Asia-Pacific
  • Asia and Oceania Federation of Obstetrics and Gynaecology
    • Asia Oceania Federation of Obstetrics and Gynecology (AOFOG)'s efforts in the cervical cancer elimination program in the Asia-Pacific [2024]
• Australia
  • Cancer Australia
    • Cervical cancer
• Belize
  • JCO Global Oncology
    • Assessment of Cervical Cancer Prevention and Treatment Infrastructure in Belize [2021]
• Botswana
  • Cancer Prevention Research
    • Assessing Nurses’ Adherence to the See-and-Treat Guidelines of Botswana’s National Cervical Cancer Prevention Programme [2020]
  • Frontiers in Oncology
    • Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs [2015]
• Brazil
  • Epidemiologia e Serviços de Saúde
    • Assessment of the production of cervical cancer care procedures in the Brazilian National Health System in 2015 [2018]
  • Revista Brasileira de Ginecologia e Obstetrícia
    • HPV infection - Screening, diagnosis and management of HPV-induced lesions [2021]
• Bulgaria
  • International Journal of Environmental Research and Public Health
    • Economic Burden of Cervical Cancer in Bulgaria [2023]
• Canada
  • BC Cancer Agency
    • Uterine Cervix
  • Canadian Cancer Society
    • Cervical cancer
  • eLife
    • Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals [2023]
  • Public Health Agency of Canada
    • Cervical Cancer
• Developing countries
  • Indian Journal of Medical and Paediatric Oncology
    • Consensus meeting and update on existing guidelines for management of cervical cancer with special emphasis on the practice in developing countries, including India [2012]
• East Africa
  • Cancers
    • National Policies to Prevent and Manage Cervical Cancer in East African Countries: A Policy Mapping Analysis [2020]
• Europe
  • European Society for Medical Oncology
    • Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2017]
  • European Society of Gynaecological Oncology
    • European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic [2020]
    • The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer [2018]
  • WHO European Region
    • Roadmap to accelerate the elimination of cervical cancer as a public health problem in the WHO European Region 2022–2030: draft for the Seventy-second Regional Committee for Europe Background document [2022]
    • Supporting the prevention, detection and treatment of cervical cancer
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities [2022]
    • Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy [2022]
    • Prevention of Cervical Cancer. Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 2 on Triage, Treatment and Follow-up [2019]
    • Prevention of Cervical Cancer. Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia [2019]
    • Establishment of the Certification System “Gynaecological Dysplasia” in Germany [2014]
• India
  • Federation of Obstetric and Gynecological Societies of India
    • Prevention and Management of Cervical Cancer [2024]
    • Screening and Management of Preinvasive Lesions of Cervix and HPV Vaccination [2018]
  • Indian Journal of Gynecologic Oncology
    • Cervical Cancer: Formulation and Implementation of Govt of India Guidelines for Screening and Management [2022]
  • JCO Global Oncology
    • Impact of COVID-19 on Outcomes for Patients With Cervical Cancer in India [2021]
• International
  • BMC Cancer
    • Prognostic evaluation and treatment strategies for cervical cancer in pregnancy: a systematic review and meta-analysis [2025]
  • Cancer Control
    • Advances and Challenges in Cervical Cancer: From Molecular Mechanisms and Global Epidemiology to Innovative Therapies and Prevention Strategies [2025]
  • Centers for Disease Control and Prevention
    • CDC Activities for Improving Implementation of Human Papillomavirus Vaccination, Cervical Cancer Screening, and Surveillance Worldwide [2017]
  • ESMO Open
    • Examining policy cohesion for cervical cancer worldwide: analysis of WHO country reports [2020]
  • Frontiers in Public Health
    • Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation [2021]
  • Gynecologic Cancer Intergroup
    • The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries [2021]
    • Advancing clinical research globally: Cervical cancer research network from Mexico [2018]
    • Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future [2016]
  • International Federation of Gynecology and Obstetrics
    • Worldwide initiatives to eliminate cervical cancer [2021]
    • Cancer of the cervix uteri: 2021 update [2021]
    • International Federation of Gynecology and Obstetrics Global Declaration on Cervical Cancer Elimination [2019]
    • Cancer of the cervix uteri [2018]
  • Preventive Medicine
    • Prevention, diagnosis and treatment of cervical cancer: A systematic review of the impact of COVID-19 on patient care [2022]
• Latin America
  • Cancer
    • Cervical cancer control in Latin America: A call to action [2015]
  • Journal of Surgical Oncology
    • Cervical cancer prevention and treatment in Latin America [2017]
• Low and middle income countries
  • Frontiers in Public Health
    • A Framework for Cervical Cancer Elimination in Low-and-Middle-Income Countries: A Scoping Review and Roadmap for Interventions and Research Priorities [2021]
  • Gynecologic Cancer Intergroup
    • The Cervix Cancer Research Network: Increasing Access to Cancer Clinical Trials in Low- and Middle-Income Countries [2015]
  • Journal of Medical Internet Research
    • Digital Health Strategies for Cervical Cancer Control in Low- and Middle-Income Countries: Systematic Review of Current Implementations and Gaps in Research [2021]
• Morocco
  • Pan African Medical Journal
    • Cervical cancer in Morocco: a literature review on risk factors, prevalence, and healthcare challenges [2025]
• New Zealand
  • New Zealand Herpes Foundation
    • Guidelines for the Management of Genital, Anal and Throat HPV Infection in New Zealand [2024]
• Papua New Guinea
  • BMJ Global Health
    • Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea [2022]
• Poland
  • Ginekologia Polska
    • Possible deferral of diagnostic and therapeutic procedures for patients with abnormal screening tests results in cervical cancer secondary prevention in current SARS-CoV-2 pandemic Interim guidelines of the Polish Society of Gynecologists and Obstetricians and the Polish Society of Colposcopy and Cervical Pathophysiology [2020]
    • Polish recommendations regarding diagnostics and treatment of cervical squamous intraepithelial lesions according to the CAP/ASCCP guidelines [2016]
• Republic of Korea
  • Journal of Gynecologic Oncology
    • Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement [2017]
• Rwanda
  • Ministry of Health Rwanda
    • Accelerated Plan for Elimination of Cervical Cancer in Rwanda 2024-2027 [2025]
• Saudi Arabia
  • Annals of Saudi Medicine
    • Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia [2016]
• South Africa
  • National Department of Health South Africa
    • Cervical Cancer Prevention and Control Policy [2017]
• Sri Lanka
  • Sri Lanka College of Obstetricians & Gynaecologists
    • Guidance for cervical screening and management in Sri Lankan health care system [2021]
• Sub-Saharan Africa
  • Frontiers in Global Women's Health
    • Community-Engaged Approaches to Cervical Cancer Prevention and Control in Sub-Saharan Africa: A Scoping Review [2021]
  • Frontiers in Oncology
    • Challenges in Prevention and Care Delivery for Women with Cervical Cancer in Sub-Saharan Africa [2016]
  • Implementation Science
    • Implementation strategies to improve cervical cancer prevention in sub-Saharan Africa: a systematic review [2018]
  • International Journal of Environmental Research and Public Health
    • Mapping Evidence on Management of Cervical Cancer in Sub-Saharan Africa: Scoping Review [2022]
  • JCO Global Oncology
    • Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervical Cancer Management [2021]
• Sweden
  • PLoS ONE
    • Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination [2015]
• Ukraine
  • World Bank
    • Cervical Cancer in Ukraine : The Continuum of Care and Implications for Action [2019]
• United Kingdom
  • British Gynaecological Cancer Society
    • British Gynaecological Cancer Society (BGCS) Cervical Cancer Guidelines: Recommendations for Practice [2020]
  • National Institute for Health and Care Excellence
    • Cervical cancer
  • NHS England
    • Cervical cancer elimination by 2040 – plan for England [2025]
• United States
  • American Cancer Society
    • Cervical Cancer
  • Cancer Epidemiology Biomarkers & Prevention
    • Prevention of Invasive Cervical Cancer in the United States: Past, Present, and Future [2012]
  • Centers for Disease Control and Prevention
    • Cervical Cancer
  • Journal of Women's Health
    • Computable Guidelines and Clinical Decision Support for Cervical Cancer Screening and Management to Improve Outcomes and Health Equity [2022]
  • M.D. Anderson Cancer Center
    • Cervical Cancer
  • National Cancer Institute
    • HPV and Cancer
  • National Comprehensive Cancer Network
    • Cervical Cancer
  • OncoLink
    • Cervical Cancer
  • Society of Gynecologic Oncology
    • Diagnosis and Management of Adenocarcinoma in Situ: A Society of Gynecologic Oncology Evidence-Based Review and Recommendations [2020]
• West Africa
  • JCO Global Oncology
    • Lessons Learnt From Pilot Cervical Cancer Screening and Treatment Programmes Integrated to Routine Primary Health Care Services in Benin, Cote d'Ivoire, and Senegal [2022]
• WHO
  • International Agency for Research on Cancer
    • Cervical cancer
  • World Health Organization
    • WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention [2021]
    • Implementation of post-market surveillance in cervical cancer programmes [2021]
    • WHO technical guidance and specifications of medical devices for screening and treatment of precancerous lesions in the prevention of cervical cancer [2020]
    • Global strategy to accelerate the elimination of cervical cancer as a public health problem [2020]
    • Improving data for decision-making: a toolkit for cervical cancer prevention and control programmes [2019]
    • A handbook on how to implement mCervicalCancer [2017]
    • Comprehensive cervical cancer control: a guide to essential practice - Second edition [2014]
    • Comprehensive cervical cancer prevention and control - a healthier future for girls and women. WHO guidance note [2013]
    • Strengthening cervical cancer prevention and control: report of the GAVI-UNFPA-WHO meeting [2010]
    • WHO Cervical Cancer Prevention and Control Costing (C4P) Tool
    • Human papillomavirus and cancer: Fact sheet
    • Cervical cancer: Fact sheet
    • Cervical cancer
    • Cervical Cancer Elimination Initiative
• WHO South-East Asia Region
  • WHO South-East Asia Region
    • Accelerating the elimination of cervical cancer as a public health problem: Towards achieving 90–70–90 targets by 2030 [2022]
    • Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030 [2021]
• WHO Western Pacific Region
  • WHO Western Pacific Region
    • Strategic framework for the comprehensive prevention and control of cervical cancer in the Western Pacific Region 2023-2030 [2023]
• Zimbabwe
  • Pan African Medical Journal
    • The COVID-19 pandemic and its implications for cervical cancer treatment and prevention in Zimbabwe: perspectives and recommendations [2021]
    • Cervical cancer in Zimbabwe: a situation analysis [2017]
• {Related topics}
  • Topic
    • HIV/AIDS and human papillomavirus
    • Gynecologic oncology
    • Cervical cancer: vaccine
    • Cervical cancer: treatment
    • Cervical cancer: screening, prevention
    • Cervical cancer: imaging
    • Cervical cancer: epidemiology
    • Cervical cancer: colposcopy, cytopathology, histopathology
    • Cervical cancer: HPV testing

Cervical cancer: colposcopy, cytopathology, histopathology

• Africa
  • BMC Health Services Research
    • Utility of colposcopy for the screening and management of cervical cancer in Africa: a cross-sectional analysis of providers' training and practices [2024]
  • PLoS ONE
    • Factors Affecting Compliance with Clinical Practice Guidelines for Pap Smear Screening among Healthcare Providers in Africa: Systematic Review and Meta-Summary of 2045 Individuals [2013]
• Australasia
  • Royal College of Pathologists of Australasia
    • Cervix excisions including LLETZ and cone biopsies
• Canada
  • Current Oncology
    • 2023 Canadian Colposcopy Guideline: A Risk-Based Approach to Management and Surveillance of Cervical Dysplasia [2023]
  • Ontario Health
    • Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario [2016]
    • The organization of colposcopy services in Ontario: recommended framework [2015]
• China
  • Bulletin of the World Health Organization
    • Cervical cancer screening aided by artificial intelligence, China [2023]
• Estonia
  • Cancer Control
    • Quality Assessment of Cervical Cytology Practices in Estonia From 2007 to 2018 [2022]
  • European Journal of Public Health
    • Cervical cancer screening history among women diagnosed with cervical cancer in Estonia 2017-18 [2023]
• Europe
  • European Federation for Colposcopy and Pathology of the Lower Genital Tract
    • European consensus statement on expert colposcopy [2023]
• International
  • Acta Cytologica
    • The Pap Test and Bethesda 2014 [2015]
  • BMC Cancer
    • Colposcopic accuracy in diagnosing squamous intraepithelial lesions: a systematic review and meta-analysis of the International Federation of Cervical Pathology and Colposcopy 2011 terminology [2023]
  • International Collaboration on Cancer Reporting
    • Dataset for the Reporting of Carcinoma of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR) [2022]
    • Carcinomas of the Cervix
  • International Society of Gynecological Pathologists
    • Tumor Typing of Endocervical Adenocarcinoma: Contemporary Review and Recommendations From the International Society of Gynecological Pathologists [2021]
    • Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists [2021]
    • The Silva Pattern-based Classification for HPV-associated Invasive Endocervical Adenocarcinoma and the Distinction Between In Situ and Invasive Adenocarcinoma: Relevant Issues and Recommendations From the International Society of Gynecological Pathologists [2021]
    • The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists [2021]
    • The ISGyP Endocervical Adenocarcinoma Project: Master Plan Summary, Acknowledgment of Participants, and Participant Responses to Final Recommendations of the Expert Panels [2021]
    • Survey Results on Pathologic Aspects of Endocervical Adenocarcinoma by the International Society of Gynecological Pathologists [2021]
    • Grading of Endocervical Adenocarcinomas: Review of the Literature and Recommendations From the International Society of Gynecological Pathologists [2021]
    • Endocervical Adenocarcinoma, Gross Examination, and Processing, Including Intraoperative Evaluation: Recommendations From the International Society of Gynecological Pathologists [2021]
  • Journal of Gynecologic Oncology
    • Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri [2019]
  • Medical Science Monitor
    • Prognostic Significance of Clinicopathological Factors Influencing Overall Survival and Event-Free Survival of Patients with Cervical Cancer: A Systematic Review and Meta-Analysis [2022]
• Ireland
  • Ireland's Health Services
    • Making a colposcopy referral
• Italy
  • BMC Health Services Research
    • Rationale and development of an on-line quality assurance programme for colposcopy in a population-based cervical screening setting in Italy [2013]
• Japan
  • PLoS ONE
    • Current status of cervical cytology during pregnancy in Japan [2021]
• Malaysia
  • Malaysian Family Physician
    • Non-Adherence to recommended Pap smear screening guidelines and its associated factors among women attending health clinic in Malaysia [2018]
• New Zealand
  • Health New Zealand
    • Colposcopy Audit Programme [2017]
• Poland
  • Ginekologia Polska
    • COLPOSCOPY 2020 — COLPOSCOPY PROTOCOLS: A Summary of the Clinical Experts Consensus Guidelines of the Polish Society of Colposcopy and Cervical Pathophysiology and the Polish Society of Gynaecologists and Obstetricians [2020]
• Republic of Korea
  • Epidemiology and Health
    • Effect of Pap smears on the long-term survival of cervical cancer patients: a nationwide population-based cohort study in Korea [2022]
  • Journal of Pathology and Translational Medicine
    • Continuous quality improvement program and its results of Korean Society for Cytopathology [2020]
    • Current Cytology Practices in Korea: A Nationwide Survey by the Korean Society for Cytopathology [2017]
  • Scientific Reports
    • Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems [2021]
• Republic of Korea, United States
  • Journal of Pathology and Translational Medicine
    • Clinical management of abnormal Pap tests: differences between US and Korean guidelines [2020]
• Sweden
  • BMJ
    • Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study [2016]
• Turkey
  • Turkish Journal of Pathology
    • What does the Data of 354,725 Patients from Turkey Tell Us About Cervical Smear Epithelial Cell Abnormalities? - The Epithelial Cell Abnormality Rate is Increasing - Quality Control Studies and Corrective Activity are Musts [2017]
• United Kingdom
  • Health Technology Assessment
    • Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: systematic reviews and economic evaluation [2018]
  • National Institute for Health and Care Excellence
    • Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I [2018]
  • NHS England
    • Cervical screening: programme and colposcopy management
    • Cervical screening: laboratory organisation
    • Cervical screening: histopathology reporting handbook
    • Cervical screening: gynaecological cytopathology EQA scheme
    • Cervical screening: dynamic spectral imaging system (DySIS)
    • Cervical screening: cytology samples external quality assessment
    • Cervical screening: cytology reporting failsafe
    • Cervical screening: cytology improvement guide
  • Public Health England
    • Human papillomavirus (HPV) primary screening: colposcopy management
  • Royal College of Pathologists
    • Dataset for histopathological reporting of cervical neoplasia [2021]
    • BPR Clinical responsibility for cytology services [2019]
• United States
  • American Society for Colposcopy and Cervical Pathology
    • Colposcopy Standards: Guidelines for Endocervical Curettage at Colposcopy [2023]
    • A Systematic Review of Tests for Postcolposcopy and Posttreatment Surveillance [2020]
    • Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States [2017]
    • Guidelines - ASCCP
    • Colposcopy Standards
  • CA: A Cancer Journal for Clinicians
    • The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer [2021]
  • Centers for Disease Control and Prevention
    • Pap Tests
  • College of American Pathologists
    • Navigating Practice Issues Related to the Unsatisfactory Cervicovaginal Papanicolaou Test: Survey Results of Laboratories Participating in the 2020 College of American Pathologists PAP Education Program [2024]
    • Current State of Cytologic-Histologic Correlation Implementation for North American and International Laboratories: Results of the College of American Pathologists Cytopathology Committee Laboratory Practices in Gynecologic Cytology Survey [2022]
    • False-Negative Interpretation of Adenocarcinoma In Situ in the College of American Pathologists Gynecologic PAP Education Program [2017]
    • Misinterpretation Rates of High-Grade Squamous Intraepithelial Lesion in the College of American Pathologists Gynecologic PAP Education and PAP Proficiency Test Program [2016]
  • Journal of Obstetrics and Gynaecology
    • The association between affordable care act implementation and the prevalence of women having ever received a Pap smear [2024]
  • Obstetrics & Gynecology
    • Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines [2019]
    • Revised Terminology for Cervical Histopathology and Its Implications for Management of High-Grade Squamous Intraepithelial Lesions of the Cervix [2012]
    • Adherence to Conservative Management Recommendations for Abnormal Pap Tests in Adolescents [2012]
  • Preventive Medicine
    • Cervical cytology screening among low-income, minority adolescents in New York City following the 2009 ACOG guidelines [2014]
  • StatPearls
    • Papanicolaou Smear
    • Colposcopy
    • Abnormal Papanicolaou Smear
• WHO
  • International Agency for Research on Cancer
    • Colposcopy and Treatment of Cervical Precancer [2017]
    • Atlas of Colposcopy: Principles and Practice [2017]
    • WHO histological classification of tumours of the uterine cervix [2004]
    • The Bethesda System [2004]
    • TNM / FIGO [2004]
    • Histopathology of the uterine cervix - digital atlas [2004]
    • Cytopathology of the uterine cervix - digital atlas [2004]
    • Colposcopy and Treatment of Cervical Intraepithelial Neoplasia: A Beginner's Manual [2003]
• {Related topics}
  • Topic
    • Cervical cancer: screening, prevention
    • Cervical cancer

Cervical cancer: epidemiology

• Africa
  • WHO African Region
    • Cervical cancer incidence and mortality with charts [2024]
    • Cancer of the cervix in the African Region: current situation and way forward [2011]
• Asia-Pacific
  • Human Vaccines & Immunotherapeutics
    • Systematic literature review on the clinical and economic burden of human papillomavirus-related diseases in select areas in the Asia-Pacific region [2024]
• Australia
  • PLoS ONE
    • Comorbidity and cervical cancer survival of Indigenous and non-Indigenous Australian women: A semi-national registry-based cohort study (2003-2012) [2018]
• Baltic countries
  • BMC Public Health
    • An overview of cervical cancer epidemiology and prevention in the Baltic States [2023]
• Bosnia and Herzegovina, Serbia
  • Medicina
    • Relationship Between Population Density, Availability of Gynecological Services, and Cervical Cancer Incidence and Mortality Across Administrative Units in Serbia and Bosnia and Herzegovina During 2016-2020 [2024]
• Brazil
  • Annals of Global Health
    • The Global Burden of Disease Study Estimates of Brazil’s Cervical Cancer Burden [2020]
  • Ciência & Saúde Coletiva
    • Secular trend of cervical cancer mortality in Brazil and regions [2025]
  • Journal of Ambulatory Care Management
    • Primary Health Care and Cervical Cancer Mortality Rates in Brazil [2017]
  • Scientific Reports
    • Temporal trends, spatial and spatiotemporal clusters of cervical cancer mortality in Brazil from 2000 to 2021 [2024]
• Brunei Darussalam
  • Singapore Medical Journal
    • Cervical cancer in Brunei Darussalam [2012]
• Bulgaria
  • Germs
    • An overview of cervical cancer epidemiology and prevention in Bulgaria [2020]
• Canada
  • Canadian Cancer Society
    • Cervical cancer statistics
• China
  • BMC Medicine
    • Prevalence, trends, and geographic distribution of human papillomavirus infection in Chinese women: a summative analysis of 2,728,321 cases [2025]
  • BMC Public Health
    • Trends in cervical cancer mortality in China from 1989 to 2018: an age-period-cohort study and Joinpoint analysis [2021]
• China, United States
  • International Journal of Environmental Research and Public Health
    • Comparison of Secular Trends in Cervical Cancer Mortality in China and the United States: An Age-Period-Cohort Analysis [2016]
• Colombia
  • Colombia Médica
    • Epidemiology of cervical cancer in Colombia [2012]
• Czech Republic
  • Frontiers in Public Health
    • Trends of cervical tumours amongst women from perspectives of demographic, socioeconomic and geographic indicators: retrospective ecological study in Czechia [2024]
• East Africa
  • Journal of Obstetrics and Gynaecology
    • Survival of women with cervical cancer in East Africa: a systematic review and meta-analysis [2023]
• East-Central Europe
  • International Journal of Environmental Research and Public Health
    • Cervical Cancer Mortality in East-Central European Countries [2020]
• Eastern and Southern Africa
  • Women's Health
    • Human Papilloma Virus infection and cervical cancer among women who sell sex in Eastern and Southern Africa: A scoping review [2021]
• Ethiopia
  • Ethiopian Journal of Health Sciences
    • Prevalence and Associated Factors of Precancerous Cervical Lesions among Women in Ethiopia: A Systematic Review and Meta-Analysis [2021]
  • PLoS ONE
    • Precancerous lesions of the cervix and its determinants among Ethiopian women: Systematic review and meta-analysis [2020]
• Finland
  • Cancer Control
    • On Exploring Hidden Structures Behind Cervical Cancer Incidence [2018]
• Germany
  • BMC Cancer
    • Cancer incidence in Germany attributable to human papillomavirus in 2013 [2017]
  • Cancer Medicine
    • Epidemiology of cervical cancer in elderly women: Analysis of incidence, treatment, and survival using German registry data [2023]
  • Robert Koch Institute
    • Cervical cancer
• Greece
  • Pathogens
    • Trends in Human Papillomavirus-Related Health Burden in Greece from 1996 to 2021 with a Focus on Cervical and Lip, Oral Cavity, and Pharyngeal Cancer [2025]
• Grenada
  • Revista Panamericana de Salud Pública
    • Prevalence of cervical cancer and associated mortality in Grenada, 2000–2010 [2016]
• India
  • BMC Cancer
    • Secular trends in incidence and mortality of cervical cancer in India and its states, 1990-2019: data from the Global Burden of Disease 2019 Study [2022]
  • eLife
    • Approximating missing epidemiological data for cervical cancer through Footprinting: A case study in India [2023]
  • International Journal of Women's Health
    • Epidemiology of cervical cancer with special focus on India [2015]
  • Reproductive Health
    • Burden of cervical cancer in India: estimates of years of life lost, years lived with disability and disability adjusted life years at national and subnational levels using the National Cancer Registry Programme data [2024]
• International
  • American Journal of Epidemiology
    • Predicting Cohort-Specific Cervical Cancer Incidence From Population-Based Surveys of Human Papilloma Virus Prevalence: A Worldwide Study [2022]
  • BMC Public Health
    • Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019 [2021]
  • BMC Women's Health
    • Favorable cervical cancer mortality-to-incidence ratios of countries with good human development index rankings and high health expenditures [2023]
  • BMJ Global Health
    • Worldwide burden of cervical human papillomavirus (HPV) in women over 50 years with abnormal cytology: a systematic review and meta-analysis [2025]
  • BMJ Open
    • Global trends and age-specific incidence and mortality of cervical cancer from 1990 to 2019: an international comparative study based on the Global Burden of Disease [2022]
  • Cancer Reports
    • Global, regional and national burden, incidence, and mortality of cervical cancer [2023]
  • Epidemiology and Health
    • The associations of tobacco use, sexually transmitted infections, HPV vaccination, and screening with the global incidence of cervical cancer: an ecological time series modeling study [2023]
  • European Journal of Public Health
    • Analysis of the global burden of cervical cancer in young women aged 15-44 years old [2024]
  • International Journal of Cancer
    • Worldwide burden of cancer attributable to HPV by site, country and HPV type [2017]
  • International Journal of Clinical Practice
    • Epidemiological Trends and Attributable Risk Burden of Cervical Cancer: An Observational Study from 1990 to 2019 [2022]
  • International Journal of Gynecological Cancer
    • Proportions and incidence of locally advanced cervical cancer: a global systematic literature review [2022]
  • JMIR Public Health and Surveillance
    • The Global, Regional, and National Burdens of Cervical Cancer Attributable to Smoking From 1990 to 2019: Population-Based Study [2022]
  • Lancet Global Health
    • Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative [2023]
    • Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis [2020]
  • PLoS ONE
    • Prevalence and determinants of late-stage presentation among cervical cancer patients, a systematic review and meta-analysis [2022]
  • Preventive Medicine
    • The role and utility of population-based cancer registries in cervical cancer surveillance and control [2021]
• Israel
  • Israel Medical Association Journal
    • Cervical Neoplasia in Israeli Jewish Women: A Review of the Characteristics in a Low Risk Population [2011]
• Japan
  • BMC Health Services Research
    • Cost of illness of the Cervical Cancer of the uterus in Japan - a time trend and future projections [2015]
  • Cancer Science
    • Trends in cervical cancer incidence and mortality of young and middle adults in Japan [2022]
• Kazakhstan
  • Asian Pacific Journal of Cancer Prevention
    • New Trends of Cervical Cancer Incidence in Kazakhstan [2021]
  • Scientific Reports
    • Cervical cancer trend in the Republic of Kazakhstan and attitudes towards cervical cancer screening in urban and rural areas [2024]
• Latin America and the Caribbean
  • BMC Public Health
    • Cervical cancer mortality among young women in Latin America and the Caribbean: trend analysis from 1997 to 2030 [2022]
  • Frontiers in Public Health
    • Addressing the burden of cervical cancer for Indigenous women in Latin America and the Caribbean: a call for action [2024]
• Latvia
  • European Journal of Public Health
    • Understanding the high-risk human papillomavirus prevalence and associated factors in the European country with a high incidence of cervical cancer [2024]
• Lebanon
  • Cancer Control
    • Cervix Uteri Cancer in Lebanon: Incidence, Temporal Trends, and Comparison to Countries From Different Regions in the World [2022]
• Low and middle income countries
  • Lancet
    • Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries [2020]
• Netherlands
  • Cancer Medicine
    • Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004–2013 [2017]
• Nordic countries
  • Acta Obstetricia et Gynecologica Scandinavica
    • An overview of cervical cancer epidemiology and prevention in Scandinavia [2018]
• Norway
  • BMC Cancer
    • Regional differences in cervical cancer incidence and associated risk behaviors among Norwegian women: a population-based study [2021]
  • BMC Women's Health
    • Cervical cancer in women under 30 years of age in Norway: a population-based cohort study [2021]
• Pakistan
  • BMC Public Health
    • National cervical cancer burden estimation through systematic review and analysis of publicly available data in Pakistan [2023]
• Peru
  • BMC Public Health
    • Cervical cancer mortality in Peru: regional trend analysis from 2008–2017 [2021]
• Puerto Rico
  • BMC Medicine
    • Recent cervical cancer incidence, stage at diagnosis, and mortality trends in Puerto Rico, 2001-2019 [2024]
• Republic of Korea
  • International Journal of Environmental Research and Public Health
    • The Burden of Cervical Cancer in Korea: A Population-Based Study [2020]
  • Journal of Gynecologic Oncology
    • Incidence and treatment outcomes of uterine cervical cancer in Korea 1999-2018 from the national cancer registry [2023]
    • Epidemiologic characteristics of cervical cancer in Korean women [2014]
  • Pathogens
    • The Prevalence of Multi-Type Infections Among Human Papillomavirus Types in Korean Women [2025]
  • PLoS ONE
    • Trends in the Incidence of In Situ and Invasive Cervical Cancer by Age Group and Histological Type in Korea from 1993 to 2009 [2013]
• Republic of Korea, Vietnam
  • Epidemiology and Health
    • Incidence and mortality of cervical cancer in Vietnam and Korea (1999-2017) [2020]
• Romania
  • Medicina
    • Cervical Cancer Mortality in Romania: Trends, Regional and Rural–Urban Inequalities, and Policy Implications [2021]
• South Africa
  • International Journal of Cancer
    • Temporal trends in the epidemiology of cervical cancer in South Africa (1994–2012) [2018]
• Spain
  • BMC Cancer
    • The end of the decline in cervical cancer mortality in Spain: trends across the period 1981–2012 [2015]
• Sub-Saharan Africa
  • BMC Cancer
    • Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review [2019]
  • British Journal of Cancer
    • Trends in cervical cancer incidence in sub-Saharan Africa [2020]
  • Vaccine
    • The Burden of Human Papillomavirus Infections and Related Diseases in Sub-Saharan Africa [2013]
• Sweden
  • Acta Obstetricia et Gynecologica Scandinavica
    • Cervical neoplasia in relation to socioeconomic and demographic factors - a nationwide cohort study (2002-2018) [2023]
  • Cancer Epidemiology Biomarkers & Prevention
    • Time Trends for Incidence and Net Survival of Cervical Cancer in Sweden 1960-2014-A Nationwide Population-Based Study [2022]
  • Gynecologic Oncology
    • Cervical cancer among Swedish women with drug use disorders: A nationwide epidemiological study [2021]
• Taiwan
  • Annals of Medicine
    • Emerging trends in cervical cancer incidence among younger Taiwanese generations: an urban-rural comparison [2025]
• Tunisia
  • Viruses
    • The Prevalence, Genotype Distribution and Risk Factors of Human Papillomavirus in Tunisia: A National-Based Study [2022]
• United Kingdom
  • Cancer Research UK
    • Cervical cancer statistics
• United States
  • American Cancer Society
    • Cervical Cancer Statistics
  • Cancer
    • Increased Age and Race-Specific Incidence of Cervical Cancer After Correction for Hysterectomy Prevalence in the United States From 2000 to 2009 [2014]
  • Cancer Control
    • Cervical Cancer Among Older Women: Analyses of Surveillance, Epidemiology and End Results Program Data [2020]
  • Centers for Disease Control and Prevention
    • Human Papillomavirus–Attributable Cancers — United States, 2012–2016 [2019]
    • Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women — United States, 2008 and 2016 [2019]
    • Trends in Human Papillomavirus–Associated Cancers — United States, 1999–2015 [2018]
    • Human Papillomavirus–Associated Cancers — United States, 2008–2012 [2016]
  • Cureus
    • Prevalence and Sociodemographic Covariates of Cervical Cancer and Its Association With Menstrual Irregularities: Findings From the 2017 National Inpatient Sample Database [2021]
  • Gynecologic Oncology
    • Trends in cervical cancer incidence in younger US women from 2000-2013 [2017]
  • International Journal of Gynecological Cancer
    • Sociodemographic characteristics and cervical cancer survival in different regions of the United States: a National Cancer Database study [2022]
  • JAMA
    • Cervical Cancer Incidence Among US Women, 2001-2019 [2022]
  • JNCI Cancer Spectrum
    • Incidence of human papillomavirus-related cancers among males and females aged 15-34 years in the United States [2023]
    • Trends in the Incidence of Human Papillomavirus-Associated Cancers by County-Level Income and Smoking Prevalence in the United States, 2000-2018 [2022]
  • Journal of Gynecologic Oncology
    • Trends in single women with malignancy of the uterine cervix in United States [2018]
  • National Cancer Institute
    • Cervical Cancer
  • PLoS ONE
    • Health disparities in cervical cancer: Estimating geographic variations of disease burden and association with key socioeconomic and demographic factors in the US [2024]
    • Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States [2017]
• WHO
  • World Health Organization
    • Complete cervical cancer profile sets [2021]
    • Cervix uteri cancer
    • Cervical cancer country profiles
• {Related topics}
  • Topic
    • Cervical cancer

Cervical cancer: HPV testing

• Africa
  • PLoS ONE
    • Prevalence of Human Papillomavirus Genotypes among African Women with Normal Cervical Cytology and Neoplasia: A Systematic Review and Meta-Analysis [2015]
• Americas
  • Pan American Health Organization
    • Integrating HPV testing in cervical cancer screening program: a manual for program managers [2016]
• Asia-Pacific
  • JCO Global Oncology
    • Self-Collection Cervical Screening in the Asia-Pacific Region: A Scoping Review of Implementation Evidence [2023]
• Australia
  • Australian Family Physician
    • HPV testing in the National Cervical Screening Program – when is it recommended? [2013]
  • Australian Journal of General Practice
    • Human papillomavirus testing as part of the renewed National Cervical Screening Program [2018]
  • BMJ
    • National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study [2022]
• Bahrain
  • BMC Cancer
    • An epidemiological study assessing the prevalence of human papillomavirus types in women in the Kingdom of Bahrain [2014]
• Bangladesh
  • BMC Public Health
    • The effect of hrHPV prevalence on cervical cancer screening strategies: a cost-effectiveness study of Bangladesh [2025]
• Bhutan
  • BMC Infectious Diseases
    • Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme [2014]
• Brazil
  • PLoS ONE
    • Comparative evaluation of HPV genotyping: A study on the performance concordance between Anyplex II HPV28 detection and Linear Array genotyping tests in nationwide studies in Brazil [2024]
  • Revista Brasileira de Ginecologia e Obstetrícia
    • Cervical Cancer Screening with HPV Testing: Updates on the Recommendation [2022]
    • Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil [2018]
• Canada
  • Canadian Agency for Drugs and Technologies in Health
    • Self-Sampling Devices for HPV Testing [2021]
    • HPV Testing for Primary Cervical Cancer Screening: Recommendations Report [2019]
  • Canadian Family Physician
    • Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women [2017]
  • Current Oncology
    • Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations [2023]
    • Are Canadian Women Prepared for the Transition to Primary HPV Testing in Cervical Screening? A National Survey of Knowledge, Attitudes, and Beliefs [2023]
  • Government of Alberta
    • HPV self-sampling implementation strategies to engage under screened communities in cervical cancer screening: a scoping review to inform screening programs [2024]
  • Public Health Agency of Canada
    • Human Papillomavirus (HPV)
• China
  • Archives of Gynecology and Obstetrics
    • Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis [2020]
  • BMC Medicine
    • Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study [2021]
  • Human Vaccines & Immunotherapeutics
    • Distribution of HPV types among women with HPV-related diseases and exploration of lineages and variants of HPV 52 and 58 among HPV-infected patients in China: A systematic literature review [2024]
  • Journal of Cancer Research and Therapeutics
    • The prevalence of multiple or single HPV infection and genotype distribution in healthy Chinese women: A systemic review [2024]
• Croatia
  • PLoS ONE
    • Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia [2017]
• Denmark
  • Cancer Medicine
    • Adherence to follow-up after the exit cervical cancer screening test at age 60-64: A nationwide register-based study [2022]
  • Journal of Lower Genital Tract Disease
    • HPV Test as Test of Cure After Conization for CIN2+: A Nationwide Register-Based Cohort Study [2022]
  • Obstetrics & Gynecology
    • Human Papillomavirus Testing in the Last Cervical Screening Round at Age 60–64 Years [2021]
  • PLoS ONE
    • Histological outcomes in HPV-screened elderly women in Denmark [2021]
• El Salvador
  • International Journal of Cancer
    • The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador [2015]
  • Journal of Lower Genital Tract Disease
    • Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador [2016]
• Estonia
  • JAMA Network Open
    • Prevaccination Prevalence of Type-Specific Human Papillomavirus Infection by Grade of Cervical Cytology in Estonia [2023]
• Ethiopia
  • Virology Journal
    • Human papillomavirus genotype distribution in Ethiopia: an updated systematic review [2022]
• Europe
  • Clinical Microbiology and Infection
    • Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans [2020]
  • Life
    • Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening [2020]
• Finland
  • BMC Women's Health
    • The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland [2015]
• Gulf Cooperation Council
  • Cancer Cytopathology
    • Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology [2019]
• High-income countries
  • BMJ Sexual & Reproductive Health
    • Women's attitudes towards a human papillomavirus-based cervical cancer screening strategy: a systematic review [2022]
• Hungary
  • Pathology & Oncology Research
    • The Prevalence of High-Risk Human Papillomavirus in Hungary—A Geographically Representative, Cross-Sectional Study [2022]
• India
  • Indian Journal of Medical Research
    • Molecular epidemiology of human papillomavirus variants in cervical cancer in India [2025]
  • JCO Global Oncology
    • Challenges in the Implementation of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in India: A Systematic Review [2023]
  • Medicine
    • Prevalence of human papilloma virus among cervical cancer patients in India: A systematic review and meta-analysis [2024]
• International
  • BMC Public Health
    • Invitation strategy of vaginal HPV self-sampling to improve participation in cervical cancer screening: a systematic review and meta-analysis of randomized trials [2024]
  • BMJ Global Health
    • HPV self-sampling for cervical cancer screening: a systematic review of values and preferences [2021]
  • Cancer Prevention Research
    • A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus–positive and -Negative Cervical Precancers [2020]
  • Clinical Microbiology and Infection
    • Commercially available molecular tests for human papillomaviruses: a global overview [2020]
    • Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? [2015]
  • Diagnostic Cytopathology
    • Statement on HPV DNA Test Utilization [2009]
  • International Journal of Cancer
    • Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women of 30 years and older [2009]
  • International Papillomavirus Society
    • IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues [2023]
  • Journal of Gynecologic Oncology
    • Accuracy of human papillomavirus tests on self-collected urine versus clinician-collected samples for the detection of cervical precancer: a systematic review and meta-analysis [2022]
  • PLoS ONE
    • Meta-Analysis on Prevalence and Attribution of Human Papillomavirus Types 52 and 58 in Cervical Neoplasia Worldwide [2014]
• Ireland
  • Health Information and Quality Authority
    • HTA of HPV testing for cervical cancer screening [2017]
• Japan
  • Asian Pacific Journal of Cancer Prevention
    • Prevalence and Risk Factors of Human Papillomavirus Infection among Japanese Female People: A Nationwide Epidemiological Survey by Self-Sampling [2021]
• Latin America
  • PLoS ONE
    • Type-Specific HPV Prevalence in Cervical Cancer and High-Grade Lesions in Latin America and the Caribbean: Systematic Review and Meta-Analysis [2011]
• Latin America, Sub-Saharan Africa
  • Systematic Reviews
    • HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysis [2023]
• Low and middle income countries
  • BMC Cancer
    • Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study [2017]
  • Frontiers in Public Health
    • Human papillomavirus self-sampling versus provider-sampling in low- and middle-income countries: a scoping review of accuracy, acceptability, cost, uptake, and equity [2024]
• Mexico
  • Asian Pacific Journal of Cancer Prevention
    • Spatial Epidemiology of Human Papillomavirus Screening Coverage in Mexico, 2013-2019 [2025]
  • International Journal of Molecular Sciences
    • Epidemiology and Molecular Biology of HPV Variants in Cervical Cancer: The State of the Art in Mexico [2022]
• Middle East, North Africa
  • Journal of Infection and Public Health
    • Human papillomavirus epidemiology in populations with normal or abnormal cervical cytology or cervical cancer in the Middle East and North Africa: A systematic review and meta-analysis [2020]
• Montenegro
  • Acta Clinica Croatica
    • HPV typing as a screening program for prevention and early detection of cervical cancer in different Montenegro regions [2020]
• Netherlands
  • BJOG: An International Journal of Obstetrics & Gynaecology
    • Cost-effectiveness of HPV-based cervical screening based on first year results in the Netherlands: a modelling study [2021]
  • International Journal of Cancer
    • Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening [2016]
    • Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended? [2014]
  • Preventive Medicine
    • HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme [2019]
• New Zealand
  • Best Practice Advocacy Centre New Zealand
    • HPV testing guide for general practice [2023]
  • PLoS ONE
    • Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand [2016]
• Nigeria
  • Asian Pacific Journal of Cancer Prevention
    • Prevalence and Type Distribution of Human Papillomavirus Recovered from the Uterine Cervix of Nigerian Women: A Systematic Review and Meta-Analysis [2020]
  • Journal of International Medical Research
    • High-risk human papillomavirus infection among Nigerian women: A systematic review and meta-analysis [2023]
• Republic of Korea
  • Journal of Gynecologic Oncology
    • High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology [2020]
• Romania
  • Annals of Global Health
    • HPV Testing for Cervical Cancer in Romania: High-Risk HPV Prevalence among Ethnic Subpopulations and Regions [2019]
• Singapore
  • Society for Colposcopy and Cervical Pathology of Singapore
    • SCCPS Scientific Committee Position Paper on HPV Self-sampling Test [2023]
    • SCCPS Scientific Committee Position Paper on Primary HPV Screening for Cervical Cancer Prevention [2016]
• Slovenia
  • Acta Dermatovenerologica Alpina, Pannonica et Adriatica
    • A review of 20 years of HPV research in Slovenia [2011]
• South Africa
  • Viruses
    • Mapping the HPV Landscape in South African Women: A Systematic Review and Meta-Analysis of Viral Genotypes, Microbiota, and Immune Signals [2024]
• Spain
  • BMC Women's Health
    • Comparative cost analysis of cervical cancer screening programme based on molecular detection of HPV in Spain [2021]
• Sub-Saharan Africa
  • BMJ Open
    • Mapping evidence on the acceptability of human papillomavirus self-sampling for cervical cancer screening among women in sub-Saharan Africa: a scoping review [2023]
  • Frontiers in Public Health
    • Prevalence and Genotype Distribution of High-Risk Human Papillomavirus Infection Among Sub-Saharan African Women: A Systematic Review and Meta-Analysis [2022]
  • Gynecologic Oncology
    • Accuracy of HPV testing on self-collected and clinician-collected samples for different screening strategies in African settings: A systematic review and meta-analysis [2022]
  • Implementation Science Communications
    • A systematic review of randomized control trials of HPV self-collection studies among women in sub-Saharan Africa using the RE-AIM framework [2021]
  • Infectious Agents and Cancer
    • Human papillomavirus self-sampling versus standard clinician-sampling for cervical cancer screening in sub-Saharan Africa: a systematic review and meta-analysis of randomized controlled trials [2021]
• Sweden
  • PLoS ONE
    • Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden [2020]
• Turkey
  • Asian Pacific Journal of Cancer Prevention
    • Analysis of the Prevalence and Quantification of Viral Load of Different Human Papillomavirus Types in Turkish Women Population [2022]
  • Turkish Journal of Obstetrics and Gynecology
    • Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey [2021]
• United Kingdom
  • NHS England
    • Cervical screening: primary HPV screening implementation
    • Cervical screening: pathway for acceptance of new HPV tests
    • Cervical screening: laboratory testing for human papillomavirus
    • Cervical screening: laboratory HPV testing and cytology services
    • Cervical screening: acceptable HPV tests
  • Public Health England
    • Human papillomavirus (HPV): primary screening protocol
• United States
  • Acta Cytologica
    • 2013 Statement on Human Papillomavirus DNA Test Utilization [2014]
  • Agency for Healthcare Research and Quality
    • Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: A Systematic Evidence Review for the U.S. Preventive Services Task Force [2018]
  • American Cancer Society
    • The time has come to implement primary human papillomavirus screening for cervical cancer in the United States [2023]
    • Implementation in action: Collaborating on the transition to primary HPV screening for cervical cancer in the United States [2023]
    • Cervical cancer prevention in the United States-where we've been and where we're going: The American Cancer Society Primary HPV Screening Initiative [2023]
  • American Journal of Managed Care
    • The Budget Impact of Cervical Cancer Screening Using HPV Primary Screening [2016]
  • American Society for Colposcopy and Cervical Pathology
    • Self-Collected Vaginal Specimens for HPV Testing: Recommendations From the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee [2025]
    • Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring Guidelines [2025]
    • A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines [2020]
  • Cancer Cytopathology
    • Primary human papillomavirus screening for cervical cancer in the United States—US Food and Drug Administration approval, clinical trials, and where we are today [2014]
  • Cancer Medicine
    • Evaluating human papillomavirus (HPV) self-sampling among Latinas in the United States: A systematic review [2024]
  • College of American Pathologists
    • Human Papillomavirus Genotyping Testing Practice in 2014: Results of a College of American Pathologists National Survey [2016]
  • Journal of the National Cancer Institute
    • Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management [2022]
  • Journal of Women's Health
    • The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis [2016]
    • Overview of the CDC Cervical Cancer (Cx3) Study: An Educational Intervention of HPV Testing for Cervical Cancer Screening [2013]
  • Preventive Medicine
    • Primary HPV testing recommendations of US providers, 2015 [2017]
  • Society of Gynecologic Oncology
    • Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance [2015]
    • Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test  [2015]
• Uzbekistan
  • Journal of Gynecologic Oncology
    • Prevalence of high-risk human papillomavirus genotypes among women in Uzbekistan, 2021-2023 [2025]
• WHO
  • International Agency for Research on Cancer
    • Using HPV tests for cervical cancer screening and managing HPV-positive women – a practical online guide [2023]
  • World Health Organization
    • WHO recommendations on self-care interventions: human papillomavirus (HPV) self-sampling as part of cervical cancer screening and treatment, 2022 update [2023]
    • WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus (HPV): web annex [2021]
    • WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus (HPV) [2021]
    • Introducing and scaling up testing for human papillomavirus as part of a comprehensive programme for prevention and control of cervical cancer [2020]
    • Human papillomavirus (HPV) self-sampling as part of cervical cancer screening [2020]
    • Human papillomavirus laboratory manual [2010]
• {Related topics}
  • Topic
    • Cervical cancer: screening, prevention
    • Cervical cancer

Cervical cancer: imaging

• Brazil
  • Revista da Associação Médica Brasileira
    • Cervical cancer - staging and restaging with 18F-FDG PET/CT [2019]
• Europe
  • European Society of Gynaecological Oncology
    • The Role of Imaging in Cervical Cancer Staging: ESGO/ESTRO/ESP Guidelines (Update 2023) [2024]
• International
  • Radiation Oncology
    • Deep learning in CT image segmentation of cervical cancer: a systematic review and meta-analysis [2022]
• United States
  • American College of Radiology
    • Pretreatment Evaluation and Follow-up of Invasive Cancer of the Cervix
• {Related topics}
  • Topic
    • Cervical cancer

Cervical cancer: screening, prevention

• Africa
  • Global Health Action
    • Cervical cancer screening decentralized policy adaptation: an African rural-context-specific systematic literature review [2019]
• Antigua and Barbuda
  • Medicina
    • Cervical Cancer and Human Papillomavirus Awareness among Women in Antigua and Barbuda [2023]
• Arab countries
  • BMC Cancer
    • Cervical cancer screening uptake in Arab countries: a systematic review with meta-analysis [2024]
• Asia-Pacific
  • PLOS Global Public Health
    • From barriers to opportunities from COVID-19 pandemic: Stakeholder perspectives on cervical cancer screening programs in LMICs of the Asia-Pacific region [2024]
• Australia
  • Australian Commission on Safety and Quality in Health Care
    • Requirements for cervical screening (Second edition 2024) [2024]
  • Australian Institute of Health and Welfare
    • National Cervical Screening Program monitoring report 2023 [2023]
    • National Cervical Screening Program data dictionary: version 1.2 [2023]
    • Cervical screening in Australia 2019 [2019]
    • Analysis of cervical cancer and abnormality outcomes in an era of cervical screening and HPV vaccination in Australia [2019]
  • Australian Journal of General Practice
    • A new era in cervical cancer prevention [2018]
  • Cancer Council
    • Cervical Cancer Screening Guidelines
  • Lancet Public Health
    • Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program [2017]
  • Public Health Research and Practice
    • Reasons that clinicians in Australia offer cervical screening outside guidelines for frequency, age and co-testing [2022]
    • Lessons from the renewal of the National Cervical Screening Program in Australia [2019]
  • Royal Australian College of General Practitioners
    • Cervical cancer
• Australia, Europe, United States
  • Medicine
    • Association of human papillomavirus vaccination with cervical cancer screening: A systematic review and meta-analysis [2022]
• Australia, New Zealand
  • Royal Australian and New Zealand College of Obstetricians and Gynaecologists
    • Cervical Cancer Screening in Australia and Aotearoa New Zealand [2024]
    • Investigation of intermenstrual and postcoital bleeding [2021]
• Bangladesh
  • BMC Public Health
    • Implementation of an electronic health information system using DHIS2 tracker to manage and evaluate the National cervical screening programme in Bangladesh [2025]
• Belgium, Switzerland
  • BMC Public Health
    • Never and under cervical cancer screening in Switzerland and Belgium: trends and inequalities [2020]
• Belize
  • Cancer Causes and Control
    • Barriers and facilitators to effective cervical cancer screening in Belize: a qualitative analysis [2023]
• Bolivia
  • Rural and Remote Health
    • Findings and lessons learned from a multi-partner collaboration to increase cervical cancer prevention efforts in Bolivia [2013]
• Brazil
  • BMC Cancer
    • Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from 2006 to 2013 [2018]
• Brazil, Chile
  • Ciência & Saúde Coletiva
    • Cervical cancer guidelines, prevention and screening strategies: experiences from Brazil and Chile [2021]
• Cameroon
  • BMC Public Health
    • Cervical cancer screening prevalence and its correlates in Cameroon: secondary data analysis of the 2018 demographic and health surveys [2021]
  • International Journal for Equity in Health
    • Disparities in cervical cancer screening programs in Cameroon: a scoping review of facilitators and barriers to implementation and uptake of screening [2023]
• Canada
  • Canadian Family Physician
    • The pandemic and cervical cancer screening: Is it finally time to adopt HPV self-swabbing tests in Canada? [2022]
    • Cervical cancer screening for young women [2020]
    • Missed connections: Unintended consequences of updated cervical cancer screening guidelines on screening rates for sexually transmitted infections [2015]
  • Canadian Task Force on Preventive Health Care
    • Cervical Cancer (2013) [2013]
  • CMAJ
    • Evidence that supports policies to delay cervical screening until after age 25 years [2017]
  • Journal of Obstetrics and Gynaecology Canada
    • Cervical Cancer Screening in Canada [2019]
• Central Asia, Eastern Europe
  • United Nations Population Fund
    • Preventing Cervical Cancer in Eastern Europe & Central Asia [2021]
• China
  • BMC Medicine
    • Development of models for cervical cancer screening: construction in a cross-sectional population and validation in two screening cohorts in China [2021]
  • BMC Women's Health
    • Knowledge, willingness, uptake and barriers of cervical cancer screening services among Chinese adult females: a national cross-sectional survey based on a large e-commerce platform [2023]
  • Cancer Communications
    • Age-specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross-sectional study [2022]
  • China CDC Weekly
    • Cervical Cancer Screening Rates Among Chinese Women — China, 2015 [2020]
  • Oncologist
    • Cervical Cancer Screening Among Adult Women in China, 2010 [2015]
• Costa Rica
  • Journal of the National Cancer Institute
    • Performance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine Trial [2022]
• Denmark
  • eLife
    • Participation in the nationwide cervical cancer screening programme in Denmark during the COVID-19 pandemic: An observational study [2023]
• East Africa
  • JCO Global Oncology
    • Burden of Risk Factors for Cervical Cancer Among Women Living in East Africa: An Analysis of the Latest Demographic Health Surveys Conducted Between 2014 and 2017 [2021]
• Estonia
  • Scientific Reports
    • Nationwide study on development and validation of a risk prediction model for CIN3+ and cervical cancer in Estonia [2024]
• Eswatini
  • Preventive Medicine
    • Cervical cancer screening by visual inspection and HPV testing in Eswatini [2022]
• Ethiopia
  • BMC Cancer
    • Cervical cancer screening practice and associated factors among female health care professionals in Ethiopia 2024: a systematic review and meta-analysis [2024]
    • Applying the Health Belief Model to cervical cancer screening uptake among women in Ethiopia: a systematic review and meta-analysis [2024]
  • Cancer Control
    • Cervical Cancer Screening Utilization and Barriers to Uptake in Ethiopia: An Umbrella Review [2024]
  • PLoS ONE
    • Determinants of cervical cancer screening intention among reproductive age women in Ethiopia: A systematic review and meta-analysis [2024]
    • Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis [2021]
• Europe
  • Eurohealth
    • Advancing equitable cervical cancer screening and early detection in Europe [2025]
  • European Society of Gynaecological Oncology
    • Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC) [2020]
  • Frontiers in Public Health
    • Factors influencing the participation of groups identified as underserved in cervical cancer screening in Europe: a scoping review of the literature [2023]
  • International Journal of Cancer
    • The European response to the WHO call to eliminate cervical cancer as a public health problem [2021]
  • PLoS ONE
    • The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort [2016]
  • WHO European Region
    • Cervical cancer testing in the WHO European Region [2021]
• Finland
  • International Journal of Environmental Research and Public Health
    • Cervical Cancer Screening Participation among Women of Russian, Somali, and Kurdish Origin Compared with the General Finnish Population: A Register-Based Study [2020]
• France
  • Haute Autorité de Santé
    • Updated evidence-based recommendations for cervical cancer screening in France [2022]
  • PLoS ONE
    • Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France [2020]
• Georgia
  • Central European Journal of Public Health
    • Evaluation of barriers to cervical cancer screening in Georgia [2023]
• Germany
  • European Journal of Obstetrics & Gynecology and Reproductive Biology
    • A model to evaluate the costs and clinical effectiveness of human papilloma virus screening compared with annual papanicolaou cytology in Germany [2017]
  • Materia Socio-Medica
    • Implementation of the Program for Early Detection of Cervical Cancer in the Federal Republic of Germany [2020]
• Ghana
  • Ghana Medical Journal
    • Recommendations for cervical cancer prevention and control in Ghana: public education and human papillomavirus vaccination [2018]
• High-income countries
  • International Journal of Gynecology & Obstetrics
    • Turning the tide-Recommendations to increase cervical cancer screening among women who are underscreened [2024]
• Hong Kong
  • Centre for Health Protection
    • Recommendations on Prevention and Screening for Cervical Cancer For Health Professionals [2021]
  • Hong Kong College of Obstetricians and Gynaecologists
    • 2024 Hong Kong College of Obstetricians and Gynaecologists Guidelines for cervical cancer prevention and screening [2024]
• India
  • BMC Cancer
    • Urban-rural disparities in cervical cancer screening among Indian women between 30-49 years: a geospatial and decomposition analysis using a nationally representative survey [2025]
  • BMC Women's Health
    • Patterns in the prevalence and wealth-based inequality of cervical cancer screening in India [2023]
  • Cancer Epidemiology
    • Implementing Community-based Cervical Cancer Screening Programs using Visual Inspection with Acetic Acid in India: A Systematic Review [2017]
  • Centers for Disease Control and Prevention
    • Establishing Baseline Cervical Cancer Screening Coverage — India, 2015–2016 [2019]
  • Indian Journal of Medical Research
    • Screening for cervical cancer: Choices & dilemmas [2021]
  • PLoS ONE
    • Cost effectiveness of strategies for cervical cancer prevention in India [2020]
  • Women's Health
    • Knowledge, attitude, and practice on screening toward cervical cancer among health professionals in India—A review [2021]
• India, Thailand
  • Asian Pacific Journal of Cancer Prevention
    • Effectiveness of Visual Inspection with Acetic Acid (VIA) Screening on Cervical Cancer Mortality and Incidence - A Systematic Review and Meta-Analysis [2022]
• Indonesia
  • Global Health Action
    • Facilitators and barriers for the delivery and uptake of cervical cancer screening in Indonesia: a scoping review [2021]
• International
  • BMC Women's Health
    • Barriers and facilitators for cervical cancer screening among adolescents and young people: a systematic review [2021]
  • Frontiers in Public Health
    • Which is the best management for women with normal cervical cytologic findings despite positivity for non-16/18 high risk human papillomaviruses? [2022]
  • Geneva Foundation for Medical Education and Research
    • Comprehensive Visual Inspection of the Cervix with Acetic Acid (VIA) and Lugol’s Iodine (VILI) [2014]
  • Globalization and Health
    • Associated factors and global adherence of cervical cancer screening in 2019: a systematic analysis and modelling study [2022]
  • International Papillomavirus Society
    • HPV prevention and control - The way forward [2022]
    • COVID-19 as a catalyst for reimagining cervical cancer prevention [2022]
    • IPVS policy statement. Equity in cervical cancer prevention: for all and not just for some [2020]
  • International Planned Parenthood Federation
    • IMAP statement on preventing cervical cancer [2016]
  • Journal of Biological Dynamics
    • Computational approaches of modelling human papillomavirus transmission and prevention strategies: a systematic review [2025]
  • Journal of Medical Internet Research
    • Electronic Health Interventions and Cervical Cancer Screening: Systematic Review and Meta-Analysis [2024]
  • Journal of Oncology
    • Cervical Cancer Screening Guidelines in the Postvaccination Era: Review of the Literature [2020]
  • Lancet Global Health
    • Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis [2022]
  • Papillomavirus Research
    • HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control [2019]
  • Scientific Reports
    • Comparative accuracy of cervical cancer screening strategies in healthy asymptomatic women: a systematic review and network meta-analysis [2022]
  • Systematic Reviews
    • A systematic review of economic evaluations of cervical cancer screening methods [2022]
  • Women's Health
    • Identifying the key barriers, facilitators and factors associated with cervical cancer screening attendance in young women: A systematic review [2025]
• Iran
  • BMC Public Health
    • Disparities in cervical cancer screening participation in Iran: a cross-sectional analysis of the 2016 nationwide STEPS survey [2020]
  • International Journal of Health Policy and Management
    • Priority Setting for Improvement of Cervical Cancer Prevention in Iran [2015]
  • PLoS ONE
    • Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer [2016]
• Ireland
  • Department of Health Ireland
    • Scoping Inquiry into the CervicalCheck Screening Programme [2024]
    • CervicalCheck [2019]
  • Ireland's Health Services
    • CervicalCheck
• Ivory Coast
  • BMC Public Health
    • Cervical cancer screening by visual inspection in Cote d'Ivoire, operational and clinical aspects according to HIV status [2012]
• Japan
  • International Journal of Gynecological Cancer
    • Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan [2017]
  • Journal of Obstetrics and Gynaecology Research
    • Impact of COVID-19 on cervical cancer screening in Japan: A survey of population-based screening in urban Japan by the Japan Society of Gynecologic Oncology [2022]
• Kenya
  • BMC Cancer
    • Multiple sexual partnership as an independent predictor of cervical cancer screening among women of reproductive age: an analysis of the 2022 Kenya demographic and health survey [2025]
  • BMC Health Services Research
    • Association between multiple dimensions of access to care and cervical cancer screening among Kenyan women: a cross-sectional analysis of the Demographic Health Survey [2024]
• Kuwait
  • Asian Pacific Journal of Cancer Prevention
    • Disparities in the Uptake of Cervical Cancer Screening in Kuwait: A Cross-Sectional Analysis of the Nationwide WHO STEPS Survey [2025]
• Latin America
  • Salud Pública de México
    • Cervical cancer screening programs in Latin America: current recommendations for facing elimination challenges [2022]
• Latvia
  • Acta Dermatovenerologica Alpina, Pannonica et Adriatica
    • Cervical cancer screening in Latvia: a brief history and recent improvements (2009-2011) [2013]
• Low and middle income countries
  • BMC Women's Health
    • Interventions to increase the uptake of cervical cancer screening in low- and middle-income countries: a systematic review and meta-analysis [2023]
    • Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review [2022]
    • Are treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic review [2010]
  • Cancer Medicine
    • Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings [2017]
  • Clinics
    • Cervical cancer screening in low- and middle-income countries: A systematic review of economic evaluation studies [2022]
  • International Journal of Cancer
    • To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings [2017]
  • JAMA
    • Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries [2020]
  • Lancet
    • Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries [2020]
  • World Health Organization
    • Cervical cancer screening in developing countries [2002]
• Malawi
  • BMC Health Services Research
    • Cost-effectiveness of approaches to cervical cancer screening in Malawi: comparison of frequencies, lesion treatment techniques, and risk-stratified approaches [2024]
  • BMC Public Health
    • Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study [2016]
  • Global Health Action
    • Health systems challenges in cervical cancer prevention program in Malawi [2015]
• Malaysia
  • BMC Women's Health
    • Factors influencing the prevalence of cervical cancer screening in Malaysia: a nationwide survey [2023]
• Mali
  • Frontiers in Public Health
    • A story-telling cloth approach to motivating cervical cancer screening in Mali [2022]
• Malta
  • Journal of Preventive Medicine and Hygiene
    • Cervical cancer and screening: knowledge, awareness and attitudes of women in Malta [2021]
• Nepal
  • Public Health
    • Cervical cancer screening utilization, and associated factors, in Nepal: a systematic review and meta-analysis [2022]
• Netherlands
  • BMJ
    • Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study [2017]
  • PLoS ONE
    • Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis [2016]
• Netherlands, United States
  • Milbank Quarterly
    • Cervical Cancer Screening in the United States and the Netherlands: A Tale of Two Countries [2012]
• New Zealand
  • Best Practice Advocacy Centre New Zealand
    • Cervical cancer – early detection and referral [2022]
  • Health New Zealand
    • HISO 10097: Cervical Screening Data and Messaging Standard [2024]
    • Review of cervical cancer occurrences in relation to screening history in New Zealand for the years 2013-2017 [2020]
    • Clinical Practice Guidelines for Cervical Screening in New Zealand 2020 [2020]
    • National Cervical Screening Programme and HPV Primary Screening
• Nigeria
  • African Health Sciences
    • Barriers to uptake of cervical cancer screening among women in Nigeria: a systematic review [2022]
  • Cancer Control
    • Cervical Cancer and Human Papillomavirus Vaccine Knowledge, Utilisation, Prevention Educational Interventions and Policy Response in Nigeria: A Scoping Review [2022]
  • Cancer Reports
    • Factors influencing cervical cancer screening practice among female health workers in Nigeria: A systematic review [2022]
• Nigeria, Nordic countries
  • International Health
    • A comparative analysis of cervical cancer prevention between Nigeria and Nordic countries that have experienced a decline in cervical cancer incidence [2021]
• Nordic countries
  • British Journal of Cancer
    • 50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence [2014]
• Norway
  • International Journal of Cancer
    • The value of improving failures within a cervical cancer screening program: An example from Norway [2014]
• Poland
  • BMC Cancer
    • The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines [2015]
  • Ginekologia Polska
    • Cervical cancer screening in Poland in current SARS-CoV-2 pandemic: Interim guidelines of the Polish Society of Gynecologists and Obstetricians and the Polish Society of Colposcopy and Cervical Pathophysiology — a summary January 2021 [2021]
  • PLoS ONE
    • Cervical Cancer Histology, Staging and Survival before and after Implementation of Organised Cervical Screening Programme in Poland [2016]
• Republic of Korea
  • Epidemiology and Health
    • Income-based disparities in the risk of distant-stage cervical cancer and 5-year mortality after the introduction of a National Cancer Screening Program in Korea [2022]
  • Journal of Gynecologic Oncology
    • Trends in cervical cancer screening rates among Korean women: results of the Korean National Cancer Screening Survey, 2005–2020 [2022]
    • Trend analysis of process quality indicators for the Korean National Cervical Cancer Screening Program from 2005 to 2013 [2021]
    • Nationwide cervical cancer screening in Korea: data from the National Health Insurance Service Cancer Screening Program and National Cancer Screening Program, 2009–2014 [2017]
    • The Korean guideline for cervical cancer screening [2015]
    • Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition [2013]
  • Obstetrics & Gynecology Science
    • Proposal for cervical cancer screening in the era of HPV vaccination [2018]
• Romania
  • International Journal of Environmental Research and Public Health
    • Challenges in the Prevention of Cervical Cancer in Romania [2021]
• Singapore
  • Singapore Medical Journal
    • Cervical cancer screening and vaccination: understanding the latest guidelines [2022]
    • Evaluation of the National Cervical Cancer Screening Programme in Singapore [2013]
  • Society for Colposcopy and Cervical Pathology of Singapore
    • Management Guidelines for Cervical Screening & Preinvasive Disease of the Cervix [2019]
• Sub-Saharan Africa
  • BMC Cancer
    • Far behind 90-70-90's screening target: the prevalence and determinants of cervical cancer screening among Sub-Saharan African women: evidence from Demographic and Health Survey [2024]
  • BMC Public Health
    • Interventions to increase uptake of cervical screening in sub-Saharan Africa: a scoping review using the integrated behavioral model [2020]
  • BMJ
    • Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies [2015]
  • BMJ Open
    • Understanding cervical cancer prevention in Africa: a qualitative systematic review of the role of men [2024]
    • Socioeconomic inequality in cervical cancer screening uptake among women in sub-Saharan Africa: a decomposition analysis of Demographic and Health Survey data [2024]
  • International Journal of Environmental Research and Public Health
    • The Role of Health Information Sources on Cervical Cancer Literacy, Knowledge, Attitudes and Screening Practices in Sub-Saharan African Women: A Systematic Review [2024]
  • International Journal of Public Health
    • "A Man With a Loving Heart": A Systematic Review of Male Involvement in Cervical Cancer Screening in Africa [2024]
  • PLoS Medicine
    • Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: A systematic analysis of population-based surveys (2000-2020) [2023]
• Sweden
  • International Journal of Cancer
    • Nationwide registry-based trial of risk-stratified cervical screening [2025]
  • PLoS Medicine
    • Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden [2017]
  • PLoS ONE
    • Socio-economic and demographic determinants affecting participation in the Swedish cervical screening program: A population-based case-control study [2018]
• Switzerland
  • European Journal of Public Health
    • Cervical cancer screening in Switzerland: cross-sectional trends (1992-2012) in social inequalities [2016]
• Taiwan
  • International Journal for Equity in Health
    • Changes in the magnitude of social inequality in the uptake of cervical cancer screening in Taiwan, a country implementing a population-based organized screening program [2014]
• Tanzania
  • BMC Health Services Research
    • Correlates associated with health insurance on cervical cancer screening in Tanzania: a comparison between the insured and uninsured women using demographic and health survey 2022 [2024]
  • PLoS ONE
    • Towards 90-70-90 targets: Individual and community level factors associated with cervical cancer screening among women of reproductive age in Tanzania: A multi-level analysis based on 2022 Tanzania demographic and health survey [2024]
• Thailand
  • Asian Pacific Journal of Cancer Prevention
    • National Cervical Cancer Screening in Thailand [2021]
• United Kingdom
  • BJOG: An International Journal of Obstetrics & Gynaecology
    • Introducing human papillomavirus (HPV) primary testing in the age of HPV vaccination: projected impact on colposcopy services in Wales [2021]
  • British Journal of Cancer
    • Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses [2021]
  • British Journal of General Practice
    • Cervical screening: the evolving landscape [2022]
    • Delays in diagnosis of young females with symptomatic cervical cancer in England: an interview-based study [2014]
  • Health Technology Assessment
    • HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT [2019]
  • Journal of Medical Screening
    • Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study [2021]
    • Cervical screening attendance and cervical cancer risk among women who have sex with women [2021]
  • NHS Digital
    • Cervical Screening (Quarterly)
  • NHS England
    • NHS cervical screening (CSP) programme
    • Cervical screening: programme overview
    • Cervical screening: professional guidance
    • Cervical screening: data and research
    • Cervical screening programme: standards
    • Cervical sample taker training PowerPoints
  • Preventive Medicine
    • Impact of screening between the ages of 60 and 64 on cumulative rates of cervical cancer to age 84y by screening history at ages 50 to 59: A population-based case-control study [2021]
  • Public Health England
    • Health matters: making cervical screening more accessible
  • Public Health Scotland
    • Scottish cervical screening programme statistics
    • Scottish Cervical Screening Programme primary care resources
  • Royal College of Obstetricians and Gynaecologists
    • Progress in Cervical Screening in the UK [2016]
  • UK National Screening Committee
    • Cervical cancer
• United States
  • Agency for Healthcare Research and Quality
    • Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force [2011]
    • Screening for Cervical Cancer [2011]
  • American Cancer Society
    • Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society [2020]
    • Cervical Cancer Screening Guidelines
  • American College of Obstetricians and Gynecologists
    • Updated Cervical Cancer Screening Guidelines [2021]
    • Cervical Cancer Screening in Low-Resource Settings [2015]
  • American College of Physicians
    • Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians [2015]
  • American Family Physician
    • Cervical Cancer Screening [2018]
  • American Journal of Obstetrics & Gynecology
    • Cost-effectiveness analysis of the 2019 American Society for Colposcopy and Cervical Pathology Risk-Based Management Consensus Guidelines for the management of abnormal cervical cancer screening tests and cancer precursors [2022]
  • American Society for Colposcopy and Cervical Pathology
    • Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus [2024]
    • 2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023 [2024]
    • Risk-Based Cervical Consensus Guidelines: Methods to Determine Management if Less Than 5 Years of Data Are Available [2022]
    • The ASCCP Cervical Cancer Screening Task Force Endorsement and Opinion on the American Cancer Society Updated Cervical Cancer Screening Guidelines [2021]
    • Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines [2020]
    • Reporting and Assessing the Quality of Diagnostic Accuracy Studies for Cervical Cancer Screening and Management [2020]
    • Moving forward—the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories [2020]
    • Incorporating Stakeholder Feedback in Guidelines Development for the Management of Abnormal Cervical Cancer Screening Tests [2020]
    • An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines [2020]
    • 2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation [2020]
    • 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors [2020]
  • American Society of Clinical Oncology
    • Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Guideline Update [2022]
    • Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline [2017]
  • Annals of Internal Medicine
    • Inefficiencies and high-value improvements in U.S. cervical cancer screening practice: A cost-effectiveness analysis [2015]
  • ASCO Educational Book
    • State of the Science: Screening, Surveillance, and Epidemiology of HPV-Related Malignancies [2021]
  • Cancer
    • A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines [2023]
    • Cervical Cancer Screening and Follow-Up in 4 Geographically Diverse US Health Care Systems, 1998 Through 2007 [2015]
  • Cancer Causes and Control
    • Use of cervical cancer preventive services among US women aged 21–29: an assessment of the 2010 Affordable Care Act rollout through 2018 [2020]
    • Estimating the Impact of Increasing Cervical Cancer Screening in the National Breast and Cervical Cancer Early Detection Program among Low-Income Women in the U.S [2020]
  • Cancer Cytopathology
    • Comparison of Cervical Cancer Screening Results Among 256,648 Women in Multiple Clinical Practices [2015]
  • Cancer Epidemiology Biomarkers & Prevention
    • Trends and Racial/Ethnic Differences in Predictors of Cervical Cancer Screening among US Women Ages 30-64 Years [2023]
  • Cancer Medicine
    • Medicaid expansions and differences in guideline-adherent cervical cancer screening between American Indian and White women [2023]
  • Centers for Disease Control and Prevention
    • Trends in Cervical Cancer Screening in Title X-Funded Health Centers — United States, 2005–2015 [2017]
  • Cleveland Clinic Journal of Medicine
    • Risk-based guidelines: Redefining management of abnormal cervical cancer screening results [2021]
  • JAMA Network Open
    • Delivering Guideline-Concordant Care for Patients With High-Risk HPV and Normal Cytologic Findings [2025]
    • Assessment of US Preventive Services Task Force Guideline–Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019 [2022]
    • Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014 [2021]
  • Journal of Cancer Education
    • Increasing Cervical Cancer Screening Among US Hispanics/Latinas: A Qualitative Systematic Review [2015]
  • Journal of Clinical Medicine
    • Current Cervical Carcinoma Screening Guidelines [2015]
  • Journal of Lower Genital Tract Disease
    • The Next Generation of Cervical Cancer Screening: Should Guidelines Focus on Best Practices for the Future or Current Screening Capacity? [2018]
    • Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines [2017]
    • Benchmarking CIN3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines [2013]
  • Journal of the National Cancer Institute
    • Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus [2017]
  • National Cancer Institute
    • Cervical Cancer Screening (PDQ®)
    • Cervical Cancer Prevention (PDQ®)
  • Oncology Nursing Forum
    • Cervical Cancer Screening Among Arab Women in the United States: An Integrative Review [2017]
  • Preventive Medicine
    • Do age-based discontinuation recommendations influence cervical cancer screening rates? Evidence from the United States' Behavioral Risk Factor Surveillance System, 2016 and 2018 [2023]
    • Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities [2021]
    • Are uninsured women in a national screening program having longer intervals between cervical cancer screening tests? [2020]
    • Changes to cervical cancer prevention guidelines: Effects on screening among U.S. women ages 15–29 [2012]
  • Society for Women's Health Research
    • Gaps and Opportunities to Improve Prevention of Human Papillomavirus-Related Cancers [2021]
  • U.S. Preventive Services Task Force
    • Cervical Cancer: Screening [2024]
• Vietnam
  • BMJ Open
    • Cervical cancer screening by cotesting method for Vietnamese women 25-55 years old: a cost-effectiveness analysis [2025]
• WHO
  • International Agency for Research on Cancer
    • Best Practices in Cervical Screening Programmes: Audit of Cancers, Legal and Ethical Frameworks, Communication, and Workforce Competencies [2023]
    • Cervical Cancer Screening [2022]
    • Atlas of visual inspection of the cervix with acetic acid for screening, triage, and assessment for treatment [2020]
    • A practical manual on visual screening for cervical neoplasia [2003]
  • World Health Organization
    • Monitoring national cervical cancer prevention and control programmes [2013]
    • Prevention of cervical cancer through screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy [2012]
    • Screening for cervical cancer
    • Cervical cancer screening - Response by country
    • Cervical cancer screening (Global Health Observatory)
• Zimbabwe
  • BMC Women's Health
    • Individual and community-level determinants of cervical cancer screening in Zimbabwe: a multi-level analyses of a nationwide survey [2022]
• {Related topics}
  • Topic
    • Cervical cancer: vaccine
    • Cervical cancer: colposcopy, cytopathology, histopathology
    • Cervical cancer: HPV testing
    • Cervical cancer

Cervical cancer: treatment

• Australia
  • Journal of Oncology
    • Excisional Treatment of Cervical Dysplasia in Australia 2004–2013: A Population-Based Study [2016]
• Canada
  • Alberta Health Services
    • Cancer of the Uterine Cervix
  • Current Oncology
    • Follow-up for cervical cancer: a Program in Evidence-Based Care systematic review and clinical practice guideline update [2016]
    • The changing landscape of brachytherapy for cervical cancer: a Canadian practice survey [2015]
  • Ontario Health
    • Three-Dimensional MR-Guided Intracavitary and Interstitial Brachytherapy for Cervical Cancer [2018]
    • Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-Based Chemotherapy and Radiation [2016]
• China
  • BMC Cancer
    • Predictive value of number of metastatic lymph nodes and lymph node ratio for prognosis of patients with FIGO 2018 stage IIICp cervical cancer: a multi-center retrospective study [2024]
    • Comparison of survival outcomes with or without Para-aortic lymphadenectomy in surgical patients with stage IB1-IIA2 cervical cancer in China from 2004 to 2016 [2021]
  • BMJ Open
    • Cost-effectiveness of robotic surgery compared to conventional laparoscopy for the management of early-stage cervical cancer: a model-based economic evaluation in China [2024]
  • Frontiers in Oncology
    • Chinese Expert Consensus on Iodine125 Seed Implantation for Recurrent Cervical Cancer in 2021 [2021]
• Denmark
  • Acta Obstetricia et Gynecologica Scandinavica
    • Time trends in the clinical management of cervical intraepithelial neoplasia grade 2: A Danish register-based study [2024]
  • BJOG: An International Journal of Obstetrics & Gynaecology
    • Conservative management of women with cervical intraepithelial neoplasia grade 2 in Denmark: a cohort study [2020]
  • BMJ
    • Short term complications of conisation and long term effects on fertility related outcomes in Denmark: register based nationwide cohort study [2025]
  • Gynecologic Oncology
    • Cervical cancer survivors and health care use: A Danish population-based register study [2021]
• Europe
  • European Journal of Obstetrics & Gynecology and Reproductive Biology
    • Treatment characteristics, HPV genotype distribution and risk of subsequent disease among women with high-grade cervical intraepithelial neoplasia in Europe: A systematic literature review [2024]
  • European Organisation for Research and Treatment of Cancer
    • Quality assurance for radical hysterectomy for cervical cancer: the view of the European Organization for Research and Treatment of Cancer—Gynecological Cancer Group (EORTC-GCG) [2009]
  • European Society for Gynaecological Endoscopy
    • The role of minimally invasive radical hysterectomy for cervical cancer: ESGE-SERGS position document and joint-statement [2020]
  • European Society for Medical Oncology
    • eUpdate – Cervical Cancer Treatment Recommendations [2020]
  • European Society of Gynaecological Oncology
    • ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023 [2023]
    • ESGO/ESTRO quality indicators for radiation therapy of cervical cancer [2023]
    • European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer [2020]
• Europe, United States
  • European Association of Nuclear Medicine
    • EANM/SNMMI practice guideline for [18F]FDG PET/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0 [2021]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Aspects of Therapy for Cervical Cancer in Germany 2012 – Results from a Survey of German Gynaecological Hospitals [2013]
  • Institute for Quality and Efficiency in Health Care
    • Cemiplimab (cervical cancer): Benefit assessment according to §35a SGB V [2023]
• India
  • Journal of Contemporary Brachytherapy
    • Indian Brachytherapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy [2019]
• International
  • Annals of Surgical Oncology
    • Fertility-Sparing Treatment for Early-Stage Cervical Cancer >= 2 cm: A Problem with a Thousand Nuances-A Systematic Review of Oncological Outcomes [2022]
  • Archives of Gynecology and Obstetrics
    • Perioperative morbidity of different operative approaches in early cervical carcinoma: a systematic review and meta-analysis comparing minimally invasive versus open radical hysterectomy [2022]
  • BMC Women's Health
    • Persistent HPV infection after conization of cervical intraepithelial neoplasia-- a systematic review and meta-analysis [2023]
  • Cancers
    • Management for Cervical Cancer Patients: A Comparison of the Guidelines from the International Scientific Societies (ESGO-NCCN-ASCO-AIOM-FIGO-BGCS-SEOM-ESMO-JSGO) [2024]
  • International Atomic Energy Agency
    • Addressing the burden of cervical cancer through IAEA global brachytherapy initiatives [2020]
  • International Journal of Radiation Oncology
    • Comparison and Consensus Guidelines for Delineation of Clinical Target Volume for CT- and MR-Based Brachytherapy in Locally Advanced Cervical Cancer [2014]
  • International Wound Journal
    • Effect of minimally invasive surgery and laparotomy on wound infection and postoperative and intraoperative complications in the management of cervical cancer: A meta-analysis [2023]
  • JAMA Network Open
    • Red Blood Cell Transfusion Practices for Patients With Cervical Cancer Undergoing Radiotherapy [2021]
  • JCO Global Oncology
    • Essential Package of Palliative Care for Women With Cervical Cancer: Responding to the Suffering of a Highly Vulnerable Population [2021]
  • PLoS ONE
    • Current evidence and future direction on evaluating the anticancer effects of curcumin, gingerols, and shogaols in cervical cancer: A systematic review [2024]
  • Radiotherapy and Oncology
    • IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer [2021]
  • Taiwanese Journal of Obstetrics and Gynecology
    • Comparison of adjuvant chemoradiotherapy versus radiotherapy in early-stage cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis [2022]
• Japan
  • Gynecologic Oncology
    • Fertility-sparing trachelectomy for early-stage cervical cancer: A proposal of an ideal candidate [2020]
  • Journal of Gynecologic Oncology
    • Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment [2024]
    • The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee [2021]
    • Quality indicators for cervical cancer care in Japan [2018]
  • Journal of Radiation Research
    • Recommendations for high-risk clinical target volume definition with computed tomography for three-dimensional image-guided brachytherapy in cervical cancer patients [2017]
    • A surveillance study of intensity-modulated radiation therapy for postoperative cervical cancer in Japan [2015]
• Low and middle income countries
  • Family Medicine and Community Health
    • Side effects and acceptability measures for thermal ablation as a treatment for cervical precancer in low-income and middle-income countries: a systematic review and meta-synthesis [2022]
  • Gynecologic Oncology Reports
    • Cervical cancer in low and middle income countries: Addressing barriers to radiotherapy delivery [2017]
  • International Atomic Energy Agency
    • Management of Cervical Cancer: Strategies for Limited-resource Centres - A Guide for Radiation Oncologists [2013]
  • Lancet Oncology
    • Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact [2019]
• Netherlands
  • European Journal of Cancer
    • Survival of patients with early-stage cervical cancer after abdominal or laparoscopic radical hysterectomy: a nationwide cohort study and literature review [2020]
• Poland
  • PLoS ONE
    • Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations [2019]
• Republic of Korea
  • Journal of Gynecologic Oncology
    • Clinical practice guidelines for cervical cancer: an update of the Korean Society of Gynecologic Oncology Guidelines [2025]
    • Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelines [2024]
    • Patterns of definitive radiotherapy practice for cervical cancer in South Korea: a survey endorsed by the Korean Radiation Oncology Group (KROG 20-06) [2021]
    • Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement [2019]
    • Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer [2015]
  • PLoS ONE
    • Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with lymphovascular space invasion who wish to save fertility? A systematic review and guideline recommendation [2018]
• Spain
  • Sociedad Española de Oncología Médica
    • SEOM-GEICO Clinical Guidelines on cervical cancer (2023) [2024]
    • SEOM clinical guidelines for cervical cancer (2019) [2020]
    • SEOM guidelines for cervical cancer [2015]
• Sri Lanka
  • Sri Lanka College of Obstetricians & Gynaecologists
    • Management of histologically confirmed cervical cancer [2021]
• Sub-Saharan Africa
  • Oncologist
    • Cervical Cancer in Sub-Saharan Africa: A Multinational Population-Based Cohort Study of Care and Guideline Adherence [2021]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer [2023]
    • Minimally invasive radical hysterectomy for early stage cervical cancer [2021]
    • Topotecan for the treatment of recurrent carcinoma of the cervix [2009]
  • Royal College of Obstetricians and Gynaecologists
    • Reproductive Outcomes after Local Treatment for Preinvasive Cervical Disease [2016]
• United States
  • American College of Obstetricians and Gynecologists
    • Updated Guidelines for Management of Cervical Cancer Screening Abnormalities [2020]
  • American College of Radiology
    • Role of adjuvant therapy in the management of early stage cervical cancer
  • American Society for Radiation Oncology
    • Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline [2020]
    • Radiation Therapy for Cervical Cancer: An ASTRO Clinical Practice Guideline [2020]
  • American Society of Clinical Oncology
    • Management and Care of Patients With Invasive Cervical Cancer: ASCO Resource-Stratified Guideline Rapid Recommendation Update [2022]
    • Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline [2016]
  • Current Oncology
    • Trends in Early-Stage Cervical Cancer Management in the US: A National Cancer Database Analysis [2024]
  • Gynecologic Oncology
    • Cervical Excisional Treatment of Young Women: A Population-based Study [2014]
  • National Cancer Institute
    • Cervical Cancer Treatment (PDQ®)
  • National Comprehensive Cancer Network
    • NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024 [2023]
  • OncoTargets and Therapy
    • Profile of bevacizumab and its potential in the treatment of cervical cancer [2015]
  • Society of Gynecologic Oncology
    • Cervical cancer - times… they are a changing: A report from the Society of Gynecologic Oncology journal club [2022]
    • SGO member update: Emerging data on the surgical approach for radical hysterectomy in the treatment of women with cervical cancer [2019]
• Vietnam
  • Gynecologic Cancer Intergroup
    • Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCRN) Education Symposium [2023]
• WHO
  • World Health Organization
    • Technical specifications of radiotherapy equipment for cancer treatment [2021]
    • WHO framework for strengthening and scaling-up services for the management of invasive cervical cancer [2020]
    • WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions [2019]
    • Treatment of cervical intraepithelial neoplasia 2–3 and adenocarcinoma in situ: cryotherapy, large loop excision of the transformation zone, and cold knife conization [2014]
    • Cryosurgical equipment for the treatment of precancerous cervical lesions and prevention of cervical cancer [2012]
    • WHO guidelines: use of cryotherapy for cervical intraepithelial neoplasia [2011]
    • Treating invasive cervical cancer
• {Related topics}
  • Topic
    • Cervical cancer

Cervical cancer: vaccine

• Africa
  • Human Vaccines & Immunotherapeutics
    • Exploring the complexity of the implementation determinants of human papillomavirus vaccination in Africa through a systems thinking lens: A rapid review [2024]
• Africa, Asia
  • Asian Pacific Journal of Cancer Prevention
    • Racial Disparities Associated with the Prevalence of Vaccine and Non-Vaccine HPV Types and Multiple HPV Infections between Asia and Africa: A Systematic Review and Meta-Analysis [2021]
• Americas
  • Pan American Health Organization
    • Methodology to calculate HPV Vaccine Coverage in the Region of the Americas [2019]
    • Human Papillomavirus (HPV) Vaccine
• Asia-Pacific
  • Asia and Oceania Federation of Obstetrics and Gynaecology
    • The AOFOG recommendations on human papillomavirus vaccination in the Asia-Pacific region [2024]
  • Human Vaccines & Immunotherapeutics
    • Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region [2024]
• Australia
  • Australian Institute of Health and Welfare
    • HPV immunisation rates 2015–16 [2018]
  • Australian Journal of General Practice
    • Human papillomavirus vaccination update: Nonavalent vaccine and the two-dose schedule [2018]
  • Department of Health and Aged Care
    • Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia [2020]
    • Human papillomavirus (HPV) | The Australian Immunisation Handbook
  • EuroSurveillance
    • The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? [2018]
  • Lancet Public Health
    • Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis [2016]
  • PLoS ONE
    • Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia [2018]
• Australia, New Zealand
  • Royal Australian and New Zealand College of Obstetricians and Gynaecologists
    • Guidelines for Human Papillomavirus (HPV) Vaccine [2019]
• Austria
  • BMC Infectious Diseases
    • Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria [2016]
• Bangladesh
  • PLoS ONE
    • Acceptance of Human Papillomavirus (HPV) vaccine among the parents of eligible daughters (9-15 years) in Bangladesh: A nationwide study using Health Belief Model [2024]
• Brazil
  • Revista Latino-Americana de Enfermagem
    • Vaccination against human papillomavirus in Brazilian schoolchildren: National Survey of School Health, 2019 [2022]
• Canada
  • BMC Infectious Diseases
    • Canadian oncogenic human papillomavirus cervical infection prevalence: Systematic review and meta-analysis [2011]
  • Canadian Family Physician
    • Effect of human papillomavirus vaccination on sexual behaviour among young females [2018]
    • Update on the new 9-valent vaccine for human papillomavirus prevention [2016]
    • HPV vaccine for cancer and wart prevention [2015]
  • Canadian Paediatric Society
    • Human papillomavirus vaccine for children and adolescents [2018]
  • Human Vaccines & Immunotherapeutics
    • Estimates and determinants of HPV non-vaccination in 14-year-old Canadians: Results from the childhood national immunization coverage survey, 2019 [2024]
    • Barriers and facilitators in uptake of human papillomavirus vaccine across English Canada: A review [2023]
  • Perinatal Services BC
    • HPV Immunization Series
  • Public Health Agency of Canada
    • Updated recommendations on human papillomavirus vaccines [2024]
    • Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance on human papillomavirus (HPV) vaccines [2024]
    • Human papillomavirus (HPV) vaccines: Canadian Immunization Guide
• Caribbean
  • Pan American Health Organization
    • HPV Vaccination: Toward the Elimination of Cervical Cancer in the Caribbean Countries. Virtual Meeting Report, 22–23 and 29–30 October 2020 [2021]
• Chile
  • BMC Public Health
    • Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model [2014]
• China
  • BMC Health Services Research
    • Willingness to pay for HPV vaccine among female health care workers in a Chinese nationwide survey [2022]
  • BMC Infectious Diseases
    • Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China [2017]
  • BMC Public Health
    • Human papillomavirus vaccination at the national and provincial levels in China: a cost-effectiveness analysis using the PRIME model [2022]
    • Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studies [2016]
  • European Journal of Cancer Care
    • Acceptability of and barriers to human papillomavirus vaccination in China: A systematic review of the Chinese and English scientific literature [2022]
  • Frontiers in Public Health
    • Frequency of health care provider recommendations for HPV vaccination: a survey in three large cities in China [2023]
    • A national cross-sectional study on the influencing factors of low HPV vaccination coverage in mainland China [2023]
  • Human Vaccines & Immunotherapeutics
    • Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese women [2021]
  • International Journal of Environmental Research and Public Health
    • HPV Vaccination Intentions of Female Students in Chinese Universities: A Systematic Literature Review and Meta-Analysis [2022]
  • Preventive Medicine
    • A nationwide post-marketing survey of knowledge, attitudes and recommendations towards human papillomavirus vaccines among healthcare providers in China [2021]
• Costa Rica
  • Journal of the National Cancer Institute
    • Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine Trial [2023]
  • Lancet Oncology
    • Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial [2022]
• Cyprus
  • BMC Women's Health
    • An analysis of the knowledge of adults aged between 18 and 45 on HPV along with their attitudes and beliefs about HPV vaccine: the Cyprus case [2023]
• Czech Republic
  • BMC Public Health
    • Burden of HPV-induced diseases and cost effectiveness of catch-up vaccination in Czech Republic: a model-based study [2025]
• Denmark
  • Acta Obstetricia et Gynecologica Scandinavica
    • High-grade cervical lesions after vaccination against human papillomavirus: A Danish cohort study [2020]
  • International Journal of Cancer
    • Incidence of cervical precancerous lesions and cervical cancer in Denmark from 2000 to 2019: Population impact of multi-cohort vaccination against human papillomavirus infection [2023]
    • Prevalence of high-risk human papillomavirus after HPV-vaccination in Denmark [2020]
• Developing countries
  • Infectious Diseases in Obstetrics and Gynecology
    • Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries [2011]
• Estonia
  • BMC Infectious Diseases
    • The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia [2013]
• Ethiopia
  • BMC Public Health
    • Human papillomavirus vaccine acceptance among adolescent girls in Ethiopia: a systematic review and meta-analysis [2023]
  • BMC Women's Health
    • Knowledge, attitude, and uptake of human papillomavirus vaccine among adolescent schoolgirls in Ethiopia: a systematic review and meta-analysis [2023]
  • Frontiers in Public Health
    • A call for switching to a 1-dose 9vHPV national vaccination program in Ethiopia [2023]
• Europe
  • BMC Public Health
    • The structural and organizational aspects of human papillomavirus vaccine affecting immunization coverage in Europe: a systematic review [2025]
  • Cancer Medicine
    • HPV-vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level [2019]
  • European Centre for Disease Prevention and Control
    • Efficacy, effectiveness and safety of HPV vaccination in women with conisation: a systematic review and meta-analyses [2024]
    • Vaccine Scheduler - Human Papillomavirus Infection
    • Human papillomavirus
  • European Society of Gynaecological Oncology
    • Prophylactic HPV vaccination in HPV-related gynecologic cancers: European Society of Gynecological Oncology (ESGO) prevention committee opinion [2025]
    • Human papillomavirus vaccination: The ESGO–EFC position paper of the European society of Gynaecologic Oncology and the European Federation for colposcopy [2019]
  • EuroSurveillance
    • Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma [2021]
  • WHO European Region
    • Questions and answers about human papillomavirus, second edition [2024]
    • Communicating with caregivers about the Human Papillomavirus vaccination: facilitator’s guide [2023]
    • Communicating with caregivers about the Human Papillomavirus vaccination: a tool to build confidence in communication skills among health workers [2023]
• Fiji
  • BMC Public Health
    • Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents [2015]
• France
  • EuroSurveillance
    • Can physicians and schools mitigate social inequalities in human papillomavirus vaccine awareness, uptake and vaccination intention among adolescents? A cross-sectional study, France, 2021 to 2022 [2023]
  • Human Vaccines & Immunotherapeutics
    • Human Papillomavirus vaccination in general practice in France, three years after the implementation of a targeted vaccine recommendation based on age and sexual history [2015]
    • A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France [2013]
• Germany
  • Frontiers in Public Health
    • Human papillomavirus prevalence and vaccine effectiveness in young women in Germany, 2017/2018: results from a nationwide study [2023]
• Greece
  • In Vivo
    • Cervical Pathology Following HPV Vaccination in Greece: A 10-year HeCPA Observational Cohort Study [2020]
• High-income countries
  • BMC Public Health
    • Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis [2014]
  • Expert Review of Vaccines
    • A review of data systems for assessing the impact of HPV vaccination in selected high-income countries [2023]
  • Lancet
    • Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis [2019]
• Hong Kong
  • PLoS ONE
    • Uptake of human papillomavirus (HPV) vaccination in Hong Kong: Facilitators and barriers among adolescent girls and their parents [2018]
• India
  • Asian Pacific Journal of Cancer Prevention
    • Methodological Assessment of a Review of Knowledge, Attitude and Practice about Human Papilloma Virus Vaccination in India [2024]
    • Evidence of Knowledge, Attitude, and Practice Regarding Human Papilloma Virus Vaccination at the Community Level in India: A Systematic Review and Meta-analysis [2024]
    • HPV Vaccination of Girl Child in India: Intervention for Primary Prevention of Cervical Cancer [2018]
  • Cancer Control
    • Gender-Neutral HPV Vaccine in India; Requisite for a Healthy Community: A Review [2024]
• Indonesia
  • Asian Pacific Journal of Cancer Prevention
    • HPV Vaccination Program in Indonesia: Effectiveness, Dose, Scale-Up Costs, Future Prospects, and Policy Recommendations [2025]
  • PLoS ONE
    • Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis [2020]
• International
  • BMC Infectious Diseases
    • Prevalence of non-vaccine high-risk HPV cervical infections in vaccinated women: a systematic review and meta-analysis [2025]
  • BMC Public Health
    • A systematic review of interventions to promote HPV vaccination globally [2023]
  • BMC Women's Health
    • Global parental acceptance, attitudes, and knowledge regarding human papillomavirus vaccinations for their children: a systematic literature review and meta-analysis [2024]
  • Frontiers in Public Health
    • Gender-neutral vs. gender-specific strategies in school-based HPV vaccination programs: a systematic review and meta-analysis [2025]
  • Human Vaccines & Immunotherapeutics
    • Healthcare worker practices for HPV vaccine recommendation: A systematic review and meta-analysis [2024]
    • A systematic literature review of human papillomavirus vaccination strategies in delivery systems within national and regional immunization programs [2024]
  • International Federation of Gynecology and Obstetrics
    • FIGO guidance for sustainable implementation of vaccination programs for women: Pregnancy and HPV [2023]
    • Safety of HPV vaccination: a FIGO statement [2013]
  • International Journal of STD & AIDS
    • A targeted literature review of health economic analyses of human papillomavirus vaccination from various countries [2023]
  • International Papillomavirus Society
    • IPVS statement on “Temporary HPV vaccine shortage: Implications globally to achieve equity” [2020]
  • Journal of Clinical Virology
    • 2023 global inventory of commercial molecular tests for human papillomaviruses (HPV) [2024]
  • Journal of Medical Internet Research
    • Effects of Message Framing on Human Papillomavirus Vaccination: Systematic Review [2024]
  • Journal of the National Cancer Institute. Monographs
    • Human papillomavirus prophylactic vaccines: update on new vaccine development and implications for single-dose policy [2024]
  • Lancet Public Health
    • Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis [2021]
  • PLoS ONE
    • Perspectives of HPV vaccine decision-making among young adults: A qualitative systematic review and evidence synthesis [2025]
  • Preventive Medicine Reports
    • Cost and effectiveness of HPV vaccine delivery strategies: A systematic review [2022]
• Iran
  • Intervirology
    • Type-Specific Human Papillomavirus Prevalence in Iranian Women with Normal Cervical Cytology: The Impact of Current HPV Vaccines [2017]
• Ireland
  • Royal College of Physicians of Ireland
    • Updated recommendations for HPV vaccination [2022]
• Islamic countries
  • PLoS ONE
    • Religious beliefs and practices toward HPV vaccine acceptance in Islamic countries: A scoping review [2024]
• Israel
  • Journal of Lower Genital Tract Disease
    • Impact of COVID-19 Pandemic on Human Papillomavirus Vaccine Uptake in Israel [2023]
• Italy
  • Human Vaccines & Immunotherapeutics
    • A cost-effectiveness analysis of adult human papillomavirus vaccination strategies in Italy [2025]
• Japan
  • Cancer Science
    • Even though active recommendation for HPV vaccination has restarted, Japan's rates have not recovered [2024]
    • Disparities among Japanese municipalities in recommendations for routine and catch-up HPV vaccinations [2023]
    • A nationwide birth year-by-year analysis of effectiveness of HPV vaccine in Japan [2021]
    • Reduction in HPV16/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination program [2019]
  • Human Vaccines & Immunotherapeutics
    • A questionnaire survey on the prevention of HPV infection among females and males who came of age in Japan under various scenarios of HPV vaccine recommendation [2023]
    • Changing trends in HPV vaccination in Japan [2022]
    • Health consciousness and cervical cancer screening rates in HPV-unvaccinated girls: comparison from HPV-recommended and HPV-recommendation-suspended program periods [2021]
  • Lancet Regional Health – Western Pacific
    • The looming health hazard: A wave of HPV-related cancers in Japan is becoming a reality due to the continued suspension of the governmental recommendation of HPV vaccine [2021]
    • Suspension of proactive recommendations for HPV vaccination has led to a significant increase in HPV infection rates in young Japanese women: real-world data [2021]
  • Scientific Reports
    • Potential for cervical cancer incidence and death resulting from Japan’s current policy of prolonged suspension of its governmental recommendation of the HPV vaccine [2020]
    • Dynamic changes in Japan’s prevalence of abnormal findings in cervical cytology depending on birth year [2018]
  • Vaccine
    • Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis [2022]
  • Vaccines
    • Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program [2022]
• Kenya
  • EClinicalMedicine
    • Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: A mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence [2022]
• Latin America and the Caribbean
  • Pan American Health Organization
    • Evaluating the impact of the human papillomavirus vaccine in Latin America and the Caribbean [2023]
• Lebanon
  • BMC Pediatrics
    • Human papillomavirus vaccine knowledge and conspiracy beliefs among secondary school students in Lebanon [2023]
• Low and middle income countries
  • BMC Health Services Research
    • Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014 [2016]
  • Human Vaccines & Immunotherapeutics
    • Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives [2022]
  • JNCI Cancer Spectrum
    • Human Papillomavirus Vaccination After COVID-19 [2021]
  • Jornal de Pediatria
    • HPV vaccination programs in LMIC: is it time to optimize schedules and recommendations? [2023]
  • Public Health
    • Features of human papillomavirus vaccination education strategies in low- and middle-income countries: a scoping review [2022]
  • Vaccine
    • Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review [2022]
    • Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects [2013]
• Luxembourg
  • Cancer Epidemiology
    • Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in Luxembourg [2019]
• Malaysia
  • BMC Public Health
    • Cost- effectiveness of HPV vaccination regime: comparing twice versus thrice vaccinations dose regime among adolescent girls in Malaysia [2016]
  • Frontiers in Public Health
    • The impact of the COVID-19 pandemic on the national HPV immunization program in Malaysia [2022]
• Middle East, North Africa
  • Eastern Mediterranean Health Journal
    • Knowledge, awareness and acceptability of anti-HPV vaccine in the Arab states of the Middle East and North Africa Region: a systematic review [2018]
• Morocco
  • Pan African Medical Journal
    • Human papillomavirus vaccination in view of the National Cancer Control Plan 2020-2029 in Morocco [2023]
• Netherlands
  • International Journal of Cancer
    • Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen-detected cervical precancer [2021]
• New Zealand
  • Health New Zealand
    • Human papillomavirus
  • New Zealand Herpes Foundation
    • HPV Vaccine [2024]
• Nigeria
  • BMC Health Services Research
    • Cost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage [2017]
• Norway
  • BMC Public Health
    • Time trends in HPV vaccination according to country background: a nationwide register-based study among girls in Norway [2021]
  • PLoS ONE
    • Prevention of HPV-Related Cancers in Norway: Cost-Effectiveness of Expanding the HPV Vaccination Program to Include Pre-Adolescent Boys [2014]
  • Preventive Medicine
    • Correlates of HPV vaccine uptake in school-based routine vaccination of preadolescent girls in Norway: A register-based study of 90,000 girls and their parents [2015]
• Peru
  • PLoS ONE
    • Parental Acceptance of HPV Vaccine in Peru: A Decision Framework [2012]
• Philippines
  • BMC Public Health
    • A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines [2015]
  • Cost Effectiveness and Resource Allocation
    • Incorporating economies of scale in the cost estimation in economic evaluation of PCV and HPV vaccination programmes in the Philippines: a game changer? [2018]
  • Vaccine
    • The cost-effectiveness of human papillomavirus vaccination in the Philippines [2022]
• Republic of Korea
  • International Journal of Environmental Research and Public Health
    • Factors Associated with the HPV Vaccination among Korean Americans and Koreans: A Systematic Review [2021]
  • Investigative and Clinical Urology
    • 2023 Korean sexually transmitted infections guidelines by the Korean Association of Urogenital Tract Infection and Inflammation: Human papillomavirus vaccination [2024]
  • Journal of Gynecologic Oncology
    • Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines [2021]
    • Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline [2019]
    • Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline [2016]
  • Virology Journal
    • Enhanced disease progression due to persistent HPV-16/58 infections in Korean women: a systematic review and the Korea HPV cohort study [2021]
• Saudi Arabia
  • Frontiers in Oncology
    • HPV Infection in Cervical and Other Cancers in Saudi Arabia: Implication for Prevention and Vaccination [2014]
  • Frontiers in Public Health
    • Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescent females across Saudi Arabia [2025]
• Senegal
  • Vaccine
    • National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learned [2022]
    • Cost of human papillomavirus vaccine delivery in a single-age cohort, routine-based vaccination program in Senegal [2022]
• Serbia
  • PLoS ONE
    • Strengthening the role of community pharmacy in HPV vaccination roll-out in Serbia at national and local levels: A pharmacy-based education approach [2025]
• Singapore
  • Society for Colposcopy and Cervical Pathology of Singapore
    • SCCPS Scientific Committee Position Paper on HPV Vaccination [2020]
• South Africa
  • BMC Infectious Diseases
    • Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence [2015]
  • Clinical Drug Investigation
    • Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa [2022]
• South Asia
  • Frontiers in Public Health
    • Uptake and determinants of HPV vaccination in South Asia: a systematic review and meta-analysis [2024]
• Spain
  • EuroSurveillance
    • Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016 [2019]
  • Human Vaccines & Immunotherapeutics
    • Cost-effectiveness and epidemiological impact of gender-neutral HPV vaccination in Spain [2022]
• Sub-Saharan Africa
  • BMC Public Health
    • Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review [2023]
  • BMJ Open
    • Communication strategies to improve human papillomavirus (HPV) immunisation uptake among adolescents in sub-Saharan Africa: a systematic review and meta-analysis [2023]
  • Human Vaccines & Immunotherapeutics
    • Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa: A systematic review and meta-analysis [2024]
    • Human papillomavirus vaccination coverage among young women in the three sub-Saharan African countries using Demographic and Health Surveys data [2024]
  • PLoS ONE
    • Knowledge and Awareness of HPV Vaccine and Acceptability to Vaccinate in Sub-Saharan Africa: A Systematic Review [2014]
• Sweden
  • American Journal of Epidemiology
    • Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs [2021]
  • Archives of Gynecology and Obstetrics
    • Human papilloma virus (HPV) prevalence upon HPV vaccination in Swedish youth: a review based on our findings 2008–2018, and perspectives on cancer prevention [2021]
  • British Journal of Cancer
    • Impact of HPV vaccination on cervical screening performance: a population-based cohort study [2020]
• Switzerland
  • BMC Infectious Diseases
    • Impact of HPV vaccination with Gardasil® in Switzerland [2017]
  • BMC Public Health
    • Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland [2020]
  • BMJ Open
    • Vaccine hesitancy and HPV vaccine uptake among male and female youth in Switzerland: a cross-sectional study [2022]
• Tanzania
  • Health Policy and Planning
    • Feasibility and acceptability of delivering adolescent health interventions alongside HPV vaccination in Tanzania [2016]
  • Vaccine
    • Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019 [2022]
    • National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation [2022]
    • Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania's national HPV vaccine introduction [2022]
• Thailand
  • Human Vaccines & Immunotherapeutics
    • Effectiveness of HPV vaccine as part of national immunization program for preventing HPV infection in Thai schoolgirls after seven years post-vaccination [2024]
  • Journal of Gynecologic Oncology
    • Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting [2024]
  • PLoS ONE
    • The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand [2021]
• Togo
  • Vaccine
    • Promoting adolescent health through integrated human papillomavirus vaccination programs: The experience of Togo [2022]
• Tunisia
  • BMJ Open
    • Cost-effectiveness of human papillomavirus (HPV) vaccination in Tunisia: a modelling study [2024]
• Uganda
  • Infectious Agents and Cancer
    • Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review [2011]
  • Vaccine
    • Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country [2018]
• United Kingdom
  • BMC Infectious Diseases
    • Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK [2019]
  • BMJ
    • Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study [2024]
    • Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study [2019]
  • HSC Public Health Agency
    • Human papillomavirus (HPV) immunisation programme - Factsheet for healthcare professionals [2023]
  • Human Vaccines & Immunotherapeutics
    • Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom [2015]
  • JAMA Network Open
    • Cost-Effectiveness of 9-Valent HPV Vaccination for Patients Treated for High-Grade Cervical Intraepithelial Neoplasia in the UK [2024]
  • PLoS ONE
    • HPV Serology Testing Confirms High HPV Immunisation Coverage in England [2016]
  • Public Health Scotland
    • HPV immunisation statistics Scotland
    • HPV education pack
  • UK Health Security Agency
    • Human papillomavirus (HPV): the green book, chapter 18a
    • HPV vaccination programme
    • Adolescent vaccination programme in secondary schools for 2024 to 2025
  • Vaccine
    • Risk of spontaneous abortion and other pregnancy outcomes in 15–25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom [2015]
• United States
  • Academic Pediatrics
    • Recommending Human Papillomavirus Vaccination at Age 9: A National Survey of Primary Care Professionals [2022]
  • American Academy of Pediatrics
    • Why AAP recommends initiating HPV vaccination as early as age 9 [2019]
  • American Cancer Society
    • Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation [2020]
    • Guidelines for Human Papillomavirus Vaccine Use
  • American College of Obstetricians and Gynecologists
    • Adjuvant Human Papillomavirus Vaccination for Patients Undergoing Treatment for Cervical Intraepithelial Neoplasia 2+ [2023]
    • Human Papillomavirus Vaccination [2020]
  • American Society for Colposcopy and Cervical Pathology
    • ASCCP Committee Opinion: Adjuvant Human Papillomavirus Vaccine for Patients Undergoing Treatment for Cervical Intraepithelial Neoplasia [2023]
  • American Society of Clinical Oncology
    • Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline [2017]
    • American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention [2016]
  • BMC Pediatrics
    • Factors associated with parental reasons for “no-intent” to vaccinate female adolescents with human papillomavirus vaccine: National Immunization Survey - Teen 2008–2012 [2017]
  • CA: A Cancer Journal for Clinicians
    • Clinician communication strategies associated with increased uptake of the human papillomavirus (HPV) vaccine: A systematic review [2022]
  • Cancer Causes and Control
    • Lower human papillomavirus vaccine initiation and completion among Asian American adolescents compared to their peers: National Health and Nutritional Examination Survey 2011-2018 [2023]
  • Cancer Epidemiology Biomarkers & Prevention
    • Disparities in healthcare providers’ recommendation of HPV vaccination for US adolescents: A systematic review [2021]
    • Assessing Impact of HPV Vaccination on Cervical Cancer Incidence in Women 15–29 years in the United States, 1999–2017: An Ecologic Study [2021]
  • Centers for Disease Control and Prevention
    • Trends in Cervical Precancers Identified Through Population-Based Surveillance — Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United States, 2008–2022 [2025]
    • Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine — United States, 2003–2018 [2021]
    • Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices [2019]
    • Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices [2016]
    • Human Papillomavirus (HPV) Vaccine Safety
    • HPV Vaccination: For Providers
  • Food and Drug Administration
    • Gardasil
  • Frontiers in Oncology
    • Preventing Cervical Cancer in the United States: Barriers and Resolutions for HPV Vaccination [2016]
  • Human Vaccines & Immunotherapeutics
    • Human papillomavirus vaccination at age 9 or 10 years to increase coverage - a narrative review of the literature, United States 2014-2024 [2025]
    • High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003-2006 and 2015-2018 [2024]
    • Recommending HPV vaccination at age 9 to reduce health disparities: Communication challenges and opportunities [2023]
    • Individual, systemic and state factors associated with provider recommendation of HPV vaccination: Findings from NIS-Teen, 2020 [2023]
    • How to make effective HPV vaccine recommendations starting at age 9 [2023]
    • HPV vaccine recommendations by age: A survey of providers in federally qualified health centers [2023]
    • Framing of national HPV vaccine recommendations and willingness to recommend at ages 9-10 [2023]
    • Evidence supporting the initiation of HPV vaccination starting at age 9: Collection overview [2023]
    • Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen [2023]
    • Why the American Academy of Pediatrics recommends initiating HPV vaccine at age 9 [2022]
    • The influence of parent-child gender on intentions to refuse HPV vaccination due to safety concerns/side effects, National Immunization Survey - Teen, 2010-2019 [2022]
    • Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13–17 by metropolitan statistical area (MSA) status, National Immunization Survey – Teen, 2013 – 2017 [2020]
    • Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature [2019]
    • Timing of HPV vaccine intervals among United States teens with consideration to the current ACIP schedule and the WHO 2-dose schedule [2015]
  • International Journal of Cancer
    • Defining benchmarks for tolerable risk thresholds in cancer screening: Impact of HPV vaccination on the future of cervical cancer screening [2020]
  • JAMA Health Forum
    • Prevalence of Human Papillomavirus Infection Among Women Born in the 1990s vs the 1980s and Association With HPV Vaccination in the US [2022]
    • Human Papillomavirus Vaccine Administration Trends Among Commercially Insured US Adults Aged 27-45 Years Before and After Advisory Committee on Immunization Practices Recommendation Change, 2007-2020 [2022]
  • JAMA Network Open
    • Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017 [2022]
    • Prevalence of Human Papillomavirus Infection by Number of Vaccine Doses Among US Women [2019]
  • JAMA Pediatrics
    • Human Papillomavirus Vaccination and Trends in Cervical Cancer Incidence and Mortality in the US [2022]
  • Journal of Adolescent Health
    • Getting Human Papillomavirus Vaccination Back on Track: A National Survey [2023]
    • Levels of Parental Human Papillomavirus Vaccine Hesitancy and Their Reasons for Not Intending to Vaccinate: Insights From the 2019 National Immunization Survey-Teen [2022]
  • Journal of Immigrant and Minority Health
    • Nativity Differences in Awareness and Knowledge About HPV Infection and Vaccination Among U.S. Adults: Findings from a National Population-Based Sample [2022]
  • National Cancer Institute
    • Human Papillomavirus (HPV) Vaccines
    • HPV Vaccination
  • Preventive Medicine Reports
    • Obstetrician/gynecologists’ HPV vaccination recommendations among women and girls 26 and younger [2022]
    • Association between patient characteristics and HPV vaccination recommendation for postpartum patients: A national survey of Obstetrician/Gynecologists [2022]
  • StatPearls
    • Human Papilloma Virus Vaccine
  • Vaccine
    • Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis [2021]
    • Regional variations in human papillomavirus prevalence across time in NHANES (2003–2014) [2019]
    • Primary care providers human papillomavirus vaccine recommendations for the medically underserved: A pilot study in U.S. Federally Qualified Health Centers [2014]
  • Vaccines
    • Adherence to the Recommended HPV Vaccine Dosing Schedule among Adolescents Aged 13 to 17 Years: Findings from the National Immunization Survey-Teen, 2019–2020 [2022]
• WHO
  • International Agency for Research on Cancer
    • Protection from a Single Dose of HPV Vaccine [2023]
  • World Health Organization
    • WHO preferred product characteristics for therapeutic HPV vaccines [2024]
    • Considerations for human papillomavirus (HPV) vaccine product choice, second edition [2024]
    • Considerations for human papillomavirus (HPV) vaccine product choice [2024]
    • User manual for WHO cervical cancer prevention and control costing tool: HPV vaccination module (C4P-HPV tool) [2023]
    • Human papillomavirus vaccines: WHO position paper, May 2022 [2022]
    • Global market study: HPV vaccines [2022]
    • Human papillomavirus (HPV) vaccine coverage monitoring manual [2020]
    • HPV Vaccine Coverage Monitoring Manual [2020]
    • Scaling-up HPV vaccine introduction [2016]
    • HPV vaccine communication: special considerations for a unique vaccine. 2016 update [2016]
    • Guide to introducing HPV vaccine into national immunization programmes [2016]
    • The immunological basis for immunization series: module 19: human papillomavirus infection [2011]
    • Report of the meeting on HPV vaccine coverage and impact monitoring, 16-17 November 2009, Geneva, Switzerland [2010]
    • Cervical cancer, human papillomavirus (HPV) and HPV vaccines : key points for policy-makers and health professionals [2007]
    • Immunizing against HPV
    • HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%)
• WHO Western Pacific Region
  • Vaccines
    • A Review of the Implementation Status of and National Plans on HPV Vaccination in 17 Middle-Income Countries of the WHO Western Pacific Region [2021]
• Zimbabwe
  • Asian Pacific Journal of Cancer Prevention
    • Behavioural and Social Drivers (BeSD) of HPV vaccination in Zimbabwe: A Rapid Scoping Review of Literature [2025]
  • Infectious Agents and Cancer
    • Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe [2014]
  • Vaccine
    • HPV vaccination coverage in three districts in Zimbabwe following national introduction of 0,12 month schedule among 10 to 14 year old girls [2022]
• {Related topics}
  • Topic
    • Genital warts, HPV vaccine for men
    • Cervical cancer: screening, prevention
    • Cervical cancer

Endometrial cancer

• Asia
  • European Society for Medical Oncology
    • Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer [2023]
• Australasia
  • Royal College of Pathologists of Australasia
    • Uterus endometrial and myometrial malignancies
• Australia
  • Cancer Council
    • Endometrial Cancer Clinical Guidelines
• Brazil
  • Revista da Associação Médica Brasileira
    • Endometrial carcinoma: treatment [2012]
• Bulgaria
  • Ginekologia Polska
    • Endometrial carcinoma in patients under 40 years of age: insights from the Bulgarian Cancer Registry [2023]
• Canada
  • BC Cancer Agency
    • Endometrium
  • BCGuidelines
    • Genital Tract Cancers in Females: Endometrial Cancer
  • Canadian Agency for Drugs and Technologies in Health
    • Trastuzumab Combination and Monotherapy for HER2 Advanced or Recurrent Uterine or Endometrial Cancer: A Review of Clinical Effectiveness and Cost-Effectiveness [2020]
  • Canadian Cancer Society
    • Uterine cancer
  • Ontario Health
    • Robotic-Assisted Hysterectomy for Endometrial Cancer in People With Obesity: A Health Technology Assessment [2023]
    • Systemic Therapy for Advanced or Recurrent Endometrial Cancer and Advanced or Recurrent Uterine Papillary Serous Carcinoma [2019]
    • Follow-up After Primary Therapy for Endometrial Cancer [2017]
  • Society of Obstetricians and Gynaecologists of Canada
    • Epidemiology and Investigations for Suspected Endometrial Cancer [2018]
• China
  • Reproductive Health
    • Burden of uterine cancer in China from 1990 to 2021 and 15-year projection: a systematic analysis and comparison with global levels [2024]
• Colombia
  • Revista Colombiana de Obstetricia y Ginecología
    • Colombian consensus for the molecular diagnosis of endometrial cancer [2024]
• Denmark
  • BMJ
    • Pregnancy duration and endometrial cancer risk: nationwide cohort study [2019]
  • Gynecologic Oncology
    • The SENTIREC-endo study - Risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer [2023]
• Europe
  • Cancers
    • Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists [2022]
  • European Society for Medical Oncology
    • Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up [2022]
    • ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer [2016]
  • European Society of Gynaecological Oncology
    • ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma [2023]
    • ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma [2021]
• Europe, Japan, United States
  • International Journal of Gynecology & Obstetrics
    • Sentinel lymph node mapping in endometrial cancer: A comparison of main national and international guidelines [2023]
• France
  • Journal of Gynecologic Oncology
    • Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group [2019]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) – Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer [2018]
    • Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) – Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities [2018]
  • Journal of Cancer Research and Clinical Oncology
    • Interdisciplinary S2k guidelines on the diagnosis and treatment of endometrial carcinoma [2009]
  • Robert Koch Institute
    • Cancer of the uterus (endometrial cancer)
• International
  • BMC Cancer
    • Survival outcomes in endometrial cancer patients according to diabetes: a systematic review and meta-analysis [2022]
  • British Journal of Cancer
    • Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2) [2015]
  • Cochrane Database of Systematic Reviews
    • Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer [2021]
  • Frontiers in Oncology
    • Global, Regional, and National Burden of Endometrial Cancer, 1990–2017: Results From the Global Burden of Disease Study, 2017 [2019]
  • Gynecologic Oncology
    • Survival outcomes of robotic-assisted laparoscopy versus conventional laparoscopy and laparotomy for endometrial cancer: A systematic review and meta-analysis [2023]
    • Uterine serous carcinoma [2021]
  • Human Reproduction Update
    • Chances of pregnancy and live birth among women undergoing conservative management of early-stage endometrial cancer: a systematic review and meta-analysis [2022]
  • International Collaboration on Cancer Reporting
    • Data Set for the Reporting of Endometrial Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR) [2022]
    • Endometrial Cancers
  • International Federation of Gynecology and Obstetrics
    • FIGO staging of endometrial cancer: 2023 [2023]
    • Cancer of the corpus uteri: 2021 update [2021]
    • Role of imaging in the routine management of endometrial cancer [2018]
    • Cancer of the corpus uteri [2018]
  • International Journal of Epidemiology
    • Associations of life course obesity with endometrial cancer in the Epidemiology of Endometrial Cancer Consortium (E2C2) [2023]
  • International Journal of Gynecological Cancer
    • FIGO 2023 endometrial cancer staging: too much, too soon? [2024]
  • International Society of Gynecological Pathologists
    • Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists [2019]
    • International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group [2019]
    • High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations [2019]
    • Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists [2019]
    • Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists [2019]
    • Current Practices in the Processing, Diagnosis, and Reporting of Endometrial Carcinoma: Results of a Web-based Survey by the International Society of Gynecological Pathologists (ISGyP) [2019]
  • Journal of Gynecologic Oncology
    • Levonorgestrel-releasing intrauterine system-based therapies for early-stage endometrial cancer: a systematic review and meta-analysis [2023]
  • Journal of Obstetrics and Gynaecology
    • The oncological and reproductive outcomes of fertility-preserving treatments for stage 1 grade 1 endometrial carcinoma: a systematic review and meta-analysis [2024]
  • Medicina
    • Fertility-Sparing Treatments in Endometrial Cancer: A Comprehensive Review on Efficacy, Oncological Outcomes, and Reproductive Potential [2025]
  • Obstetrics & Gynecology Science
    • Fertility-sparing treatment in early endometrial cancer: current state and future strategies [2020]
  • Surgical Oncology
    • Cytoreductive surgery in recurrent endometrial cancer: A new paradigm for surgical management? [2022]
• Israel
  • Cancer
    • Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers [2019]
• Italy
  • Frontiers in Oncology
    • Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group [2022]
  • Pathologica
    • Biomarker characterization in endometrial cancer in Italy: first survey data analysis [2022]
• Japan
  • Journal of Gynecologic Oncology
    • Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of Obstetrics and Gynecology [2023]
    • Trend and characteristics of minimally invasive surgery for patients with endometrial cancer in Japan [2023]
    • Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee [2017]
  • Tohoku Journal of Experimental Medicine
    • Efficient Screening Strategy for Lynch Syndrome in Japanese Endometrial Cancer [2015]
• Kazakhstan
  • Asian Pacific Journal of Cancer Prevention
    • Corpus Uteri Cancer in Kazakhstan: Recent Incidence Trends [2023]
• Latin America
  • International Journal of Gynecological Cancer
    • Management of endometrial cancer in Latin America: raising the standard of care and optimizing outcomes [2024]
• Netherlands
  • Cancers
    • Endometrial Cancer Incidence in Endometriosis and Adenomyosis [2021]
  • Gynecologic Oncology
    • Evaluation of a nationwide Dutch guideline to detect Lynch syndrome in patients with endometrial cancer [2021]
  • International Journal of Cancer
    • Endometrial cancer prognosis in women with endometriosis and adenomyosis: A retrospective nationwide cohort study of 40 840 women [2022]
• New Zealand
  • Best Practice Advocacy Centre New Zealand
    • Endometrial cancer – early detection and referral [2023]
  • Health New Zealand
    • Endometrial hyperplasia and cancer guidelines (non-surgical and fertility preserving management) [2023]
• Puerto Rico
  • Cancer Epidemiology
    • Examining concordance with the guidelines of the national comprehensive cancer network for the treatment of endometrial cancer in Puerto Rico [2024]
• Republic of Korea
  • Journal of Gynecologic Oncology
    • Clinical practice guidelines for uterine corpus cancer: an update to the Korean Society of Gynecologic Oncology guidelines [2025]
    • Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement [2024]
    • Pattern of practice for postoperative management of endometrial cancer in Korea: a survey by the Korean Gynecologic Oncology Group and the Korean Radiation Oncology Group (KGOG 2028-KROG 2104) [2023]
    • Conditional relative survival of patients with endometrial cancer: a Korean National Cancer Registry study [2022]
  • Oncotarget
    • Role of preoperative magnetic resonance imaging and histological assessment in identifying patients with a low risk of endometrial cancer: a Korean Gynecologic Oncology Group ancillary study [2017]
• Romania
  • Journal of Medicine and Life
    • Project for the National Program of Early Diagnosis of Endometrial Cancer Part II [2015]
    • Project for the National Program of Early Diagnosis of Endometrial Cancer Part I [2015]
    • Evaluation of endometrial cancer epidemiology in Romania [2015]
• Singapore
  • Annals Academy of Medicine Singapore
    • Singapore Cancer Network (SCAN) Guidelines for the Systemic Therapy of Endometrial (Uterine) Cancer [2015]
• South Africa
  • PLoS ONE
    • Trends and ethnic disparity in endometrial cancer mortality in South Africa (1999-2018): A population-based Age-period-cohort and Join point regression analyses [2025]
• Spain
  • Sociedad Española de Oncología Médica
    • SEOM-GEICO clinical guidelines on endometrial cancer (2021) [2022]
    • SEOM clinical guidelines for endometrial cancer (2017) [2018]
• Sri Lanka
  • Sri Lanka College of Obstetricians & Gynaecologists
    • Management of histologically confirmed endometrial cancer [2021]
• Sweden
  • Acta Obstetricia et Gynecologica Scandinavica
    • Long-term incidence of endometrial cancer after endometrial resection and ablation: A population based Swedish gynecologic cancer group (SweGCG) study [2022]
  • BMC Cancer
    • Increased incidence and improved survival in endometrial cancer in Sweden 1960-2014: a population-based registry survey [2023]
    • Survival in endometrial cancer in relation to minimally invasive surgery or open surgery – a Swedish Gynecologic Cancer Group (SweGCG) study [2021]
  • International Journal of Cancer
    • Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study—On behalf of the Swedish Gynecological Cancer Group [2017]
  • Scientific Reports
    • Conservative management of early-stage endometrial cancer for fertility preservation: a survey study among Swedish gynecologists and gynecological oncologists [2023]
• Taiwan
  • PLoS ONE
    • Nationwide Surveillance in Uterine Cancer: Survival Analysis and the Importance of Birth Cohort: 30-Year Population-Based Registry in Taiwan [2012]
  • Scientific Reports
    • Age-specific trend and birth cohort effect on different histologic types of uterine corpus cancers [2023]
• Thailand
  • Journal of Gynecologic Oncology
    • Practice guideline for management of endometrial cancer in Thailand: a Thai Gynecologic Cancer Society consensus statement [2025]
• United Kingdom
  • BMJ Open
    • Economic evaluation of different routes of surgery for the management of endometrial cancer: a retrospective cohort study [2021]
    • Surgical trends, outcomes and disparities in minimal invasive surgery for patients with endometrial cancer in England: a retrospective cohort study [2020]
  • British Gynaecological Cancer Society
    • British Gynaecological Cancer Society (BGCS) Uterine Cancer Guidelines: Recommendations for Practice [2021]
  • British Society of Urogenital Radiology
    • British Society of Urogenital Radiology (BSUR) commentary: FIGO staging of endometrial cancer 2023 update - implications for imaging [2024]
  • Cancer Research UK
    • Uterine cancer statistics
  • Clinical Oncology
    • Current Management Practices for Endometrial Cancer (EC) in the UK: A National Healthcare Professional Survey (KNOW-EC) [2024]
  • Health Technology Assessment
    • Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation [2021]
  • National Institute for Health and Care Excellence
    • Dostarlimab with platinum-based chemotherapy for treating advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency [2024]
    • Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial cancer [2023]
    • Pembrolizumab for previously treated endometrial, biliary, colorectal, gastric or small intestine cancer with high microsatellite instability or mismatch repair deficiency [2023]
    • Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency [2022]
    • Testing strategies for Lynch syndrome in people with endometrial cancer [2020]
    • Laparoscopic hysterectomy (including laparoscopic total hysterectomy and laparoscopically assisted vaginal hysterectomy) for endometrial cancer [2010]
    • Endometrial cancers
  • Royal College of Pathologists
    • Dataset for histopathological reporting of endometrial cancer [2017]
• United States
  • American Cancer Society
    • Endometrial Cancer
  • American College of Obstetricians and Gynecologists
    • Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia [2023]
  • American College of Radiology
    • Pretreatment Evaluation and Follow-Up of Endometrial Cancer
    • Management of Recurrent Endometrial Cancer
    • Advanced stage endometrial cancer
  • American Family Physician
    • Diagnosis and Management of Endometrial Cancer [2016]
  • American Journal of Obstetrics & Gynecology
    • Black and Hispanic women are less likely than White women to receive guideline-concordant endometrial cancer treatment [2020]
  • American Society for Radiation Oncology
    • Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline [2023]
    • An analysis of appropriate delivery of postoperative radiation therapy for endometrial cancer using the RAND/UCLA Appropriateness Method [2016]
  • American Society of Clinical Oncology
    • Postoperative Radiation Therapy for Endometrial Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline [2015]
  • CA: A Cancer Journal for Clinicians
    • Current recommendations and recent progress in endometrial cancer [2019]
  • Cancer Epidemiology Biomarkers & Prevention
    • The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women [2015]
  • Centers for Disease Control and Prevention
    • Uterine Cancer Incidence and Mortality — United States, 1999–2016 [2018]
    • Uterine Cancer
  • College of American Pathologists
    • Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Endometrium [2017]
  • Ethnicity & Disease
    • The Impact of Fibroids and Histologic Subtype on the Performance of US Clinical Guidelines for the Diagnosis of Endometrial Cancer among Black Women [2020]
  • European Journal of Epidemiology
    • Oral contraceptive use by formulation and endometrial cancer risk among women born in 1947–1964: The Nurses’ Health Study II, a prospective cohort study [2021]
  • Gynecologic Oncology
    • Prognostic performance of the 2023 FIGO staging schema for endometrial cancer [2024]
    • Guideline-concordant treatment is associated with improved survival among women with non-endometrioid endometrial cancer [2020]
    • National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer [2019]
    • Disparities in Uterine Cancer Epidemiology, Treatment, and Survival Among African Americans in the United States [2013]
  • In Vivo
    • Controversies in the Management of Early-stage Serous Endometrial Cancer [2021]
  • International Journal of Cancer
    • Guideline-concordant endometrial cancer treatment and survival in the Women’s Health Initiative Life and Longevity After Cancer study [2020]
  • JNCI Cancer Spectrum
    • Patterns and trends in the cause of death for patients with endometrial cancer [2023]
    • Differential trends in rising endometrial cancer incidence by age, race, and ethnicity [2023]
  • Journal of Gynecologic Oncology
    • Management of stage II endometrial cancer and subsequent oncologic outcomes: a National Cancer Database study [2020]
  • M.D. Anderson Cancer Center
    • Endometrial Cancer
  • National Cancer Institute
    • Uterine Cancer
    • Endometrial Cancer Treatment (PDQ®)
    • Endometrial Cancer Screening (PDQ®)
    • Endometrial Cancer Prevention (PDQ®)
  • National Comprehensive Cancer Network
    • Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology [2024]
    • Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology [2023]
    • NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021 [2021]
    • Uterine Neoplasms
  • Obstetrics & Gynecology
    • Trends in Uterine Cancer Mortality in the United States: A 50-Year Population-Based Analysis [2023]
  • OncoLink
    • Endometrial and Uterine Cancer
  • Oncologist
    • Adjuvant Therapy in Early-Stage Endometrial Cancer: A Systematic Review of the Evidence, Guidelines, and Clinical Practice in the U.S. [2014]
  • Society of Gynecologic Oncology
    • Advanced endometrial cancer-The next generation of treatment: A society of gynecologic oncology journal club clinical commentary [2024]
    • Molecular testing for endometrial cancer: An SGO clinical practice statement [2023]
    • Sentinel Lymph Node Mapping and Staging in Endometrial Cancer: A Society of Gynecologic Oncology Literature Review with Consensus Recommendations [2017]
    • SGO Clinical Practice Statement: The Role of Sentinel Lymph Node Mapping in Endometrial Cancer [2015]
    • SGO Clinical Practice Statement: Screening for Lynch Syndrome in Endometrial Cancer [2014]
  • StatPearls
    • Endometrial Cancer
• WHO
  • World Health Organization
    • Corpus uteri cancer
• {Related topics}
  • Topic
    • Gynecologic oncology

Gynecologic oncology

• Asia
  • Journal of Gynecologic Oncology
    • Asian Society of Gynecologic Oncology International Workshop 2018 [2019]
• Asia-Pacific
  • Asia and Oceania Federation of Obstetrics and Gynaecology
    • COVID-19 and gynecological cancers: Asia and Oceania Federation of Obstetrics and Gynecology oncology committee opinion [2021]
• Australasia
  • Royal College of Pathologists of Australasia
    • Ovary and fallopian tube - malignant setting
• Australia
  • Cancer Australia
    • Gynaecological cancers: a handbook for Aboriginal and Torres Strait Islander Health Workers and Health Practitioners [2024]
• Belarus
  • International Agency for Research on Cancer
    • Current Status and Future Direction of Breast and Cervical Cancer Prevention and Management in Belarus [2012]
• Belgium
  • BMC Health Services Research
    • The impact of regional screening policies on the diffusion of cancer screening participation in Belgium: time trends in educational inequalities in Flanders and Wallonia [2018]
• Cambodia
  • PLoS ONE
    • Breast and cervical cancer screening among women at reproductive age in Cambodia: A secondary analysis of Cambodia Demographic and Health Survey 2022 [2025]
• Canada
  • Alberta Health Services
    • Venous Thromboembolism in Gynecologic Oncology Patients
  • BC Cancer Agency
    • Gynecology
  • BCGuidelines
    • Genital Tract Cancers in Females: Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
  • Canadian Family Physician
    • Cancer screening in Canada. What’s in, what’s out, what’s coming [2021]
  • Current Oncology
    • Neoadjuvant and Adjuvant Systemic Therapy for Newly Diagnosed Stage II-IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma: A Practice Guideline [2022]
    • A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers [2022]
  • Ontario Health
    • Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma [2021]
    • An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation or Maintenance Systemic Therapy for Newly Diagnosed Stage II, III, or IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma [2021]
  • Society of Obstetricians and Gynaecologists of Canada
    • Initial Investigation and Management of Adnexal Masses [2020]
    • Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population [2017]
• China
  • BMC Cancer
    • A nationally quasi-experimental study to assess the impact of partial organized breast and cervical cancer screening programme on participation and inequalities [2020]
  • BMC Women's Health
    • Temporal trends and projections of gynecological cancers in China, 2007-2030 [2023]
    • Analysis of the disease burden trend of malignant tumors of the female reproductive system in China from 2006 to 2020 [2022]
    • Women’s cancers in China: a spatio-temporal epidemiology analysis [2021]
  • BMJ Open
    • Analysis of the disease burden of malignancies in the female reproductive system in China from 1990 to 2019: an age-period-cohort study and joinpoint analysis [2025]
  • International Journal of Public Health
    • Trends in the Disease Burden and Risk Factors of Women's Cancers in China From 1990 to 2019 [2024]
  • Journal of Gynecologic Oncology
    • Epidemiology of gynecologic cancers in China [2018]
  • Military Medical Research
    • National age-specific mortality trends for cervical and breast cancers in urban-rural areas of China from 2009 to 2021: a population-based analysis [2024]
  • Photodiagnosis and Photodynamic Therapy
    • Chinese expert consensus on the clinical applications of aminolevulinic acid-based photodynamic therapy in female lower genital tract diseases (2022) [2022]
  • Scientific Reports
    • Trends in hospitalization for female breast and gynecological cancer in China from 2004 to 2020 [2024]
• Colombia
  • BMC Cancer
    • Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: an administrative registry data analysis [2020]
• Croatia
  • Croatian Medical Journal
    • Breast and gynecological cancers in Croatia, 1988-2008 [2012]
• Denmark
  • Acta Obstetricia et Gynecologica Scandinavica
    • Ovarian and tubal cancer in Denmark: an update on incidence and survival [2016]
  • eLife
    • Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study [2023]
  • Preventive Medicine
    • Concurrent participation in breast, cervical, and colorectal cancer screening programmes in Denmark: A nationwide registry-based study [2023]
• Europe
  • Cancers
    • GYNOCARE Update: Modern Strategies to Improve Diagnosis and Treatment of Rare Gynecologic Tumors—Current Challenges and Future Directions [2021]
  • European Society for Gynaecological Endoscopy
    • ESGE/ESGO/SERGS consensus statement on surgical steps in minimally invasive surgery in gynecologic oncology: transperitoneal and extraperitioneal approach for paraaortic lymphadenectomy [2024]
  • European Society for Medical Oncology
    • ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies [2020]
  • European Society of Gynaecological Oncology
    • Genital tract microbiota composition profiles and use of prebiotics and probiotics in gynaecological cancer prevention: review of the current evidence, the European Society of Gynaecological Oncology prevention committee statement [2024]
    • Quality indicators - Cervical, ovarian, vulvar cancers [2019]
  • Society of European Robotic Gynaecological Surgery
    • Robot assisted surgery during the COVID-19 pandemic, especially for gynecological cancer: a statement of the Society of European Robotic Gynaecological Surgery (SERGS) [2020]
• France
  • Archive ouverte HAL
    • Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2 systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up) [2019]
    • Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1 Diagnostic exploration and staging, surgery, perioperative care, and pathology [2019]
  • BMC Cancer
    • Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey [2016]
  • BMC Health Services Research
    • Obstacles to the uptake of breast, cervical, and colorectal cancer screenings: what remains to be achieved by French national programmes? [2014]
  • Journal of Gynecology Obstetrics and Human Reproduction
    • Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF [2020]
• Germany
  • BMC Public Health
    • Differences in breast and cervical cancer screening between West and East Germany: a secondary analysis of a german nationwide health survey [2023]
  • Geburtshilfe und Frauenheilkunde
    • Statement of the AGO and AG-CPC on the Aftercare/Follow-up for Surgical Procedures of the Lower Genital Tract after the Introduction of a New Cancer Screening Guideline [2020]
• Ghana
  • BMC Cancer
    • Drivers of breast cancer and cervical cancer screening among women of reproductive age: insights from the Ghana Demographic and Health Survey [2024]
  • BMC Women's Health
    • Self-reported breast and cervical cancer screening practices among women in Ghana: predictive factors and reproductive health policy implications from the WHO study on global AGEing and adult health [2020]
• High-income countries
  • International Journal of Environmental Research and Public Health
    • Disability and Participation in Breast and Cervical Cancer Screening: A Systematic Review and Meta-Analysis [2022]
• India
  • BMC Cancer
    • Socio-economic and regional variation in breast and cervical cancer screening among Indian women of reproductive age: a study from National Family Health Survey, 2019-21 [2022]
  • BMC Women's Health
    • An epidemiological study of cervical and breast screening in India: district-level analysis [2020]
  • Cancer Control
    • Management of Gynecologic Cancer During COVID-19 Pandemic: South Asian Perspective [2022]
  • Cancer Epidemiology
    • Trends in breast and cervical cancer in India under National Cancer Registry Programme: An Age-Period-Cohort analysis [2021]
  • South Asian Journal of Cancer
    • Gynecological cancers: A summary of published Indian data [2016]
• International
  • Annals of Oncology
    • Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting [2019]
  • Biomarker Research
    • Epidemiological trends of women’s cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study [2021]
  • Biomedical and Environmental Sciences
    • Long-Term Survival Trend of Gynecological Cancer: A Systematic Review of Population-Based Cancer Registration Data [2024]
  • BMC Cancer
    • Global, regional, and national burden of breast, cervical, uterine, and ovarian cancer and their risk factors among women from 1990 to 2021, and projections to 2050: findings from the global burden of disease study 2021 [2025]
  • BMC Public Health
    • Health inequality and improvement gap in the prevalence of gynecological cancers among perimenopausal women globally, 1990-2019 [2025]
    • Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: an age period cohort analysis [2024]
  • Enhanced Recovery After Surgery
    • Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update [2023]
    • Outcomes of Enhanced Recovery after Surgery (ERAS) in Gynecologic Oncology: A Review [2022]
    • Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update [2019]
    • Enhanced recovery after surgery (ERAS®) in gynecologic oncology – Practical considerations for program development [2017]
    • Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations — Part I [2016]
    • Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations — Part II [2016]
  • Frontiers in Public Health
    • Developing and validating key performance indicators for breast, cervical, and colorectal cancer screening programs: a literature review and Delphi survey [2025]
  • Geburtshilfe und Frauenheilkunde
    • 2020 WHO Classification of Female Genital Tumors [2021]
  • Gynecologic Cancer Intergroup
    • How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting [2024]
    • GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: A position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee [2022]
    • Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions [2019]
    • GCIG Consensus Review: Uterine and Ovarian Leiomyosarcomas [2014]
  • Gynecologic Oncology
    • Prevention of venous thromboembolism in gynecological cancer patients undergoing major abdominopelvic surgery: A systematic review and network meta-analysis [2021]
    • Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations [2020]
  • International Collaboration on Cancer Reporting
    • Data Set for the Reporting of Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Recommendations From the International Collaboration on Cancer Reporting (ICCR) [2022]
    • Ovary, Fallopian Tube and Primary Peritoneal Carcinomas
  • International Federation of Gynecology and Obstetrics
    • Progress in the pathological arena of gynecological cancers [2021]
    • Obesity and gynecological cancers: A toxic relationship [2021]
    • Cancer of the ovary, fallopian tube, and peritoneum: 2021 update [2021]
    • COVID-19 and the impact on gynecologic cancer care [2021]
    • Targeted therapy for gynecologic cancers: Toward the era of precision medicine [2018]
    • Surgical pelvic anatomy in gynecologic oncology [2018]
    • Pathology of cancers of the female genital tract including molecular pathology [2018]
    • Palliative care in women's cancer care: Global challenges and advances [2018]
    • FIGO Cancer Report 2018 [2018]
    • Essential surgical skills for a gynecologic oncologist [2018]
    • Enhanced recovery after surgery in gynecologic oncology [2018]
    • Cancer of the ovary, fallopian tube, and peritoneum [2018]
    • Cancer in pregnancy [2018]
    • The future role of molecular staging in gynecologic cancer [2015]
    • Rehabilitation after gynecological cancer treatment [2015]
    • Principles of radiation therapy in low-resource and well-developed settings, with particular reference to cervical cancer [2015]
    • Principles of chemotherapy [2015]
    • FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication [2015]
  • International Journal of Cancer
    • Geographic and temporal variations in the incidence of vulvar and vaginal cancers [2020]
  • International Journal of Gynecological Pathology
    • Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites [2019]
  • International Society of Ultrasound in Obstetrics and Gynecology
    • ISUOG/ESGO Consensus Statement on ultrasound-guided biopsy in gynecological oncology [2025]
  • Journal of Global Health
    • Global burden of gynaecological cancers in 2022 and projections to 2050 [2024]
  • Nature Medicine
    • CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs [2023]
  • Psycho-Oncology
    • Factors promoting breast, cervical and colorectal cancer screenings participation: A systematic review [2022]
  • Scientific Reports
    • Regional differences in the disease burden and attributable risk factors of female cancers [2025]
• Iran
  • BMC Public Health
    • The 15-year national trends of genital cancer incidence among Iranian men and women; 2005-2020 [2023]
• Israel
  • Annals of Family Medicine
    • Socioeconomic Disparity Trends in Cancer Screening Among Women After Introduction of National Quality Indicators [2021]
• Italy
  • La radiologia medica
    • Prevention and management of radiotherapy-related toxicities in gynecological malignancies. Position paper on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology) [2024]
• Japan
  • BMC Public Health
    • Adherence to national guidelines for colorectal, breast, and cervical cancer screenings in Japanese workplaces: a survey-based classification of enterprises' practices into "overscreening," "underscreening," and "guideline-adherence screening" [2024]
  • International Journal of Clinical Oncology
    • Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer [2018]
  • Journal of Gynecologic Oncology
    • The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer [2021]
    • Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms [2020]
    • Clinical statistics of gynecologic cancers in Japan [2017]
  • Journal of Obstetrics and Gynaecology Research
    • Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO) [2022]
  • Journal of Radiation Research
    • Japanese Society for Radiation Oncology Consensus Guidelines of combined intracavitary and interstitial brachytherapy for gynecological cancers [2022]
  • Melanoma Research
    • Clinicopathological demographics of malignant melanomas of the vulva and vagina in Japan [2023]
• Lebanon
  • Cancer Control
    • Epidemiology of Breast, Corpus Uteri, and Ovarian Cancers in Lebanon With Emphasis on Breast Cancer Incidence Trends and Risk Factors Compared to Regional and Global Rates [2024]
• Lithuania
  • Medicina
    • Trends in Mortality Rates of Corpus Uteri and Ovarian Cancer in Lithuania, 1987–2016 [2020]
• Low and middle income countries
  • Asian Pacific Journal of Cancer Prevention
    • Barriers to Cervical Cancer and Breast Cancer Screening Uptake in Low-Income and Middle-Income Countries: A Systematic Review [2017]
  • BMJ Open
    • Timeliness of diagnosis of breast and cervical cancers and associated factors in low-income and middle-income countries: a scoping review [2022]
    • Effectiveness of interventions for improving timely diagnosis of breast and cervical cancers in low-income and middle-income countries: a systematic review [2022]
  • Health Policy and Planning
    • Barriers to cervical cancer and breast cancer screening uptake in low- and middle-income countries: a systematic review [2023]
  • International Federation of Gynecology and Obstetrics
    • Reaching the women with the greatest needs: Two models for initiation and scale-up of gynecologic oncology fellowship trainings in low-resource settings [2021]
  • JCO Global Oncology
    • Factors Influencing the Experience of Breast and Cervical Cancer Screening Among Women in Low- and Middle-Income Countries: A Systematic Review [2023]
  • PLoS ONE
    • Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries [2015]
• Malawi
  • BMC Cancer
    • Breast and cervical cancer screening services in Malawi: a systematic review [2020]
• Netherlands
  • Cancer Epidemiology
    • Incidence of gynaecological cancer during the COVID-19 pandemic: A population-based study in the Netherlands [2023]
  • Journal of Gynecologic Oncology
    • Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands [2020]
• New Zealand
  • Best Practice Advocacy Centre New Zealand
    • Gynaecological cancers – follow-up and surveillance [2023]
  • Ministry of Health New Zealand
    • Gynaecologic Cancer Follow-up: New Zealand Gynaecological Cancer Group guidelines [2015]
• Nordic countries
  • Acta Obstetricia et Gynecologica Scandinavica
    • Setting the record straight-Correcting uterine cancer incidence and mortality in the Nordic countries by reallocation of unspecified cases [2022]
  • BMC Cancer
    • Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment [2022]
• Peru
  • International Journal of Environmental Research and Public Health
    • Estimating Excess Mortality Due to Prostate, Breast, and Uterus Cancer during the COVID-19 Pandemic in Peru: A Time Series Analysis [2023]
• Poland
  • Clinical Epidemiology
    • Trends in Incidence and Mortality of Gynecological and Breast Cancers in Poland (1980–2018) [2022]
  • Medical Science Monitor
    • Assessment of Hospital Volume in the Surgical Management of Endometrial and Ovarian Cancer: A Polish Population-Based Study [2023]
  • OncoTargets and Therapy
    • Incidence and mortality rates in breast, corpus uteri, and ovarian cancers in Poland (1980–2013): an analysis of population-based data in relation to socioeconomic changes [2016]
  • Przeglad Menopauzalny = Menopause Review
    • Clinical practice recommendations for quality of life assessment in patients with gynecological cancer [2015]
• Republic of Korea
  • International Journal of Cancer
    • Statin use and incidence and mortality of breast and gynecology cancer: A cohort study using the National Health Insurance claims database [2022]
  • Journal of Gynecologic Oncology
    • Incidence trends for epithelial peritoneal, ovarian, and fallopian tube cancer during 1999–2016: a retrospective study based on the Korean National Cancer Incidence Database [2020]
    • Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015 [2019]
    • Surgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancers [2016]
    • Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy [2016]
    • Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010 [2013]
  • Journal of Korean Medical Science
    • Different Patterns of the Relationship Between Gynecological Malignancy and Obesity Index: A Nationwide Retrospective Cohort Study in Korea [2025]
  • Obstetrics & Gynecology Science
    • Informed consent forms for gynecologic cancer surgery: recommendations from the Korean Society of Gynecologic Oncology [2022]
    • The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry [2021]
• Republic of Korea, Uzbekistan
  • Medicina
    • Comparison of Breast Cancer and Cervical Cancer in Uzbekistan and Korea: The First Report of The Uzbekistan-Korea Oncology Consortium [2022]
• South Africa
  • Asian Pacific Journal of Cancer Prevention
    • Breast and Cervical Cancer Screening Prevalence and Associated Factors among Women in the South African General Population [2018]
• Spain
  • Clinical and Translational Oncology
    • Recommendations of the Spanish brachytherapy group of the Spanish Society of Radiation Oncology and the Spanish Society of Medical Physics for interstitial high-dose-rate brachytherapy for gynaecologic malignancies [2023]
  • Sociedad Española de Oncología Médica
    • SEOM-GETTHI clinical guideline for the practical management of molecular platforms (2021) [2022]
• Sub-Saharan Africa
  • Frontiers in Public Health
    • Mapping Evidence on the Burden of Breast, Cervical, and Prostate Cancers in Sub-Saharan Africa: A Scoping Review [2022]
  • Gynecologic Oncology
    • A scoping review: Facilitators and barriers of cervical cancer screening and early diagnosis of breast cancer in Sub-Saharan African health settings [2020]
  • JCO Global Oncology
    • Access to Radiation Therapy and Related Clinical Outcomes in Patients With Cervical and Breast Cancer Across Sub-Saharan Africa: A Systematic Review [2023]
• Sudan
  • Cancer Medicine
    • Part I: cancer in Sudan—burden, distribution, and trends breast, gynecological, and prostate cancers [2015]
• Sweden
  • American Journal of Obstetrics & Gynecology
    • Association of levonorgestrel-releasing intrauterine device with gynecologic and breast cancers: a national cohort study in Sweden [2024]
  • BMC Cancer
    • Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014: A population-based cohort study [2021]
• Switzerland
  • BMC Cancer
    • 40 years of progress in female cancer death risk: a Bayesian spatio-temporal mapping analysis in Switzerland [2015]
• Thailand
  • Journal of Gynecologic Oncology
    • The epidemiologic status of gynecologic cancer in Thailand [2016]
• Turkey
  • Asian Pacific Journal of Cancer Prevention
    • Perspectives of Gynecologic Oncologists on Minimally Invasive Surgery During COVID-19 Pandemic: A Turkish Society of Minimally Invasive Gynecologic Oncology (MIJOD) Survey [2022]
  • Journal of Gynecologic Oncology
    • Survival of gynecological cancers in Turkey: where are we at? [2017]
• United Kingdom
  • BMC Cancer
    • Incidence of breast and gynaecological cancers by ethnic group in England, 2001–2007: a descriptive study [2014]
  • BMC Health Services Research
    • Barriers to breast and cervical cancer screening uptake among Black, Asian, and Minority Ethnic women in the United Kingdom: evidence from a mixed-methods systematic review [2023]
  • BMC Public Health
    • The costs of treating vaginal and vulval cancer in England (2009–2015) [2020]
  • BMJ
    • Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation [2018]
  • British Gynaecological Cancer Society
    • British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024 [2024]
    • COVID19 Resources
  • British Journal of Cancer
    • Occupational cancer in Britain [2012]
  • Colorectal Disease
    • Governance models to support patient safety when undergoing maximal effort cytoreductive surgery for advanced ovarian/fallopian tube/primary peritoneal cancer – a joint statement of ACPGBI, ASGBI, AUGIS and BGCS [2022]
  • Gynecologic Oncology
    • Modifiable pre-treatment factors are associated with quality of life in women with gynaecological cancers at diagnosis and one year later: Results from the HORIZONS UK national cohort study [2022]
  • National Institute for Health and Care Excellence
    • Rucaparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy [2025]
    • Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer [2024]
    • Olaparib with bevacizumab for maintenance treatment of advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer [2024]
    • Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapy [2024]
    • Olaparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube or peritoneal cancer after 2 or more courses of platinum-based chemotherapy [2023]
    • Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer [2022]
    • Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy [2021]
    • Bevacizumab for treating relapsed, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal) [2015]
  • NHS England
    • Service specification: specialist gynaecological cancer [2024]
  • Royal College of Pathologists
    • Dataset for histopathological reporting of carcinomas and borderline tumours of the ovaries, fallopian tubes and peritoneum [2019]
  • Royal College of Radiologists
    • Gynaecological cancer: RCR consensus statements [2024]
  • Welsh Health Specialised Services Committee
    • Brachytherapy for the treatment of gynaecological malignancies for people aged 18 years and above [2024]
• United States
  • Abdominal Radiology
    • Gynecologic tumor board: a radiologist’s guide to vulvar and vaginal malignancies [2021]
  • American Journal of Clinical Dermatology
    • Malignant Melanoma of the Vulva and Vagina: A US Population-Based Study of 1863 Patients [2020]
  • American Society of Clinical Oncology
    • Paradigm change in urological, gynaecological and breast cancer management: A new practice-changing data from ASCO 2022 annual meeting [2023]
    • Gynecologic Cancer
  • Asian Nursing Research
    • Cultural Factors Associated with Breast and Cervical Cancer Screening in Korean American Women in the US: An Integrative Literature Review [2015]
  • BMC Public Health
    • A systematic review of special events to promote breast, cervical and colorectal cancer screening in the United States [2014]
  • Cancer
    • The National Breast and Cervical Cancer Early Detection Program: Toward a system of cancer screening in the United States [2014]
    • National Breast and Cervical Cancer Early Detection Program partnerships in action [2014]
    • Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs [2008]
  • Cancer Epidemiology Biomarkers & Prevention
    • Cancer-Specific Mortality in Asian American Women Diagnosed with Gynecologic Cancer: A Nationwide Population-Based Analysis [2022]
  • Centers for Disease Control and Prevention
    • Disparities in Meeting USPSTF Breast, Cervical, and Colorectal Cancer Screening Guidelines Among Women in the United States [2021]
    • National Breast and Cervical Cancer Early Detection Program
    • Gynecologic Cancers
  • Food and Drug Administration
    • U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review [2022]
  • Frontiers in Oncology
    • Disparities in Gynecological Malignancies [2016]
  • Gynecologic Oncology
    • Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies [2012]
  • Gynecologic Oncology Reports
    • Temporal trends and characteristics of suicide among women with gynecologic malignancy in the United States [2019]
  • International Journal of Environmental Research and Public Health
    • Changes in Screening Test Volume in the National Breast and Cervical Cancer Early Detection Program during the COVID-19 Pandemic, 2020-2022 [2024]
    • Are National Breast and Cervical Cancer Early Detection Program Recipients Providing Services in Counties Heavily Burdened by Breast and Cervical Cancer? [2024]
    • Health Care Access Measures and Palliative Care Use by Race/Ethnicity among Metastatic Gynecological Cancer Patients in the United States [2021]
  • International Journal of Gynecological Cancer
    • Disparities in gynecologic cancer incidence, treatment, and survival: a narrative review of outcomes among black and white women in the United States [2023]
  • Journal of General Internal Medicine
    • Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines [2015]
  • M.D. Anderson Cancer Center
    • Gynecologic Oncology Center
  • National Cancer Institute
    • Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (PDQ®)
    • Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Prevention (PDQ®)
    • Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)
    • Childhood Cervical and Vaginal Cancer Treatment (PDQ®)
  • National Comprehensive Cancer Network
    • NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024 [2024]
    • Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer
  • OncoLink
    • Gynecologic Cancers
  • Society for Immunotherapy of Cancer
    • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer [2023]
  • Society of Gynecologic Oncology
    • Society of Gynecologic Oncology Journal Club: Controversial conversations in Gynecologic cancer - The ABCs of ADCs (Antibody drug Conjugates) [2023]
    • Immunotherapy toxicities: An SGO clinical practice statement [2022]
    • Clinical outcomes in patients with COVID-19 and gynecologic cancer: A society of gynecologic oncology COVID-19 and gynecologic cancer registry study [2022]
    • When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 Pandemic [2020]
    • Anti-cancer Therapy and Clinical Trial Considerations for Gynecologic Oncology Patients During the COVID-19 Pandemic Crisis [2020]
    • The “value” of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendations [2017]
    • Opioid Use in Gynecologic Oncology; Balancing Efficacy, Accessibility and Safety: An SGO Clinical Practice Statement [2017]
    • An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations [2017]
    • Improving quality and decreasing cost in gynecologic oncology care: Society of Gynecologic Oncology recommendations for clinical practice [2015]
    • Comprehensive care in gynecologic oncology: The importance of palliative care [2015]
  • U.S. Department of Veterans Affairs
    • Evidence Brief: Accuracy of Self-report for Cervical and Breast Cancer Screening [2019]
• WHO Eastern Mediterranean Region
  • WHO Eastern Mediterranean Region
    • Women’s cancer in the WHO Eastern Mediterranean Region: situation analysis and investment case report [2024]
• {Related topics}
  • Topic
    • Vulvar cancer
    • Vaginal cancer
    • Uterine sarcoma
    • Tubal cancer
    • Trophoblastic neoplasms, gestational trophoblastic disease
    • Ovarian cancer
    • Hereditary gynecologic cancer, genetic predisposition
    • Gynecologic surgery
    • Fertility preservation
    • Endometrial cancer
    • Cervical cancer
    • Breast cancer

Hereditary gynecologic cancer, genetic predisposition

• Americas
  • JCO Global Oncology
    • Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional Study [2022]
• Arab countries
  • BMC Cancer
    • Prevalence of BRCA mutations among hereditary breast and/or ovarian cancer patients in Arab countries: systematic review and meta-analysis [2019]
• Asia
  • Asia-Pacific Journal of Clinical Oncology
    • Current practices and challenges in genetic testing and counseling for women with breast and ovarian cancer in Asia [2024]
• Australia
  • Hereditary Cancer in Clinical Practice
    • Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice [2021]
  • Royal Australian College of General Practitioners
    • Familial breast and ovarian cancer
• Austria
  • Archives of Gynecology and Obstetrics
    • AGO Austria recommendation on screening and diagnosis of Lynch syndrome (LS) [2017]
• Brazil
  • European Journal of Medical Research
    • Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario [2024]
  • JCO Global Oncology
    • Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil [2020]
• Canada
  • Ontario Health
    • Hereditary Cancer Testing Eligibility Criteria: Version 3.1 [2024]
    • Risk reduction strategies for BRCA1/2 hereditary ovarian cancer syndromes: a clinical practice guideline [2021]
  • Society of Obstetricians and Gynaecologists of Canada
    • Gynaecologic Management of Hereditary Breast and Ovarian Cancer [2018]
• Caribbean
  • JAMA Network Open
    • Gene Sequencing for Pathogenic Variants Among Adults With Breast and Ovarian Cancer in the Caribbean [2021]
• Europe
  • European Molecular Genetics Quality Network
    • EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer [2024]
    • A comparative study of germline BRCA1 and BRCA2 mutation screening methods in use in 20 European clinical diagnostic laboratories [2017]
  • European Society for Medical Oncology
    • Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline [2023]
    • Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening [2016]
• France
  • Cancers
    • TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing [2021]
  • Frontiers in Oncology
    • GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers [2018]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer [2020]
  • Journal of Cancer Research and Clinical Oncology
    • The risk of endocrine interventions in carriers of a genetic predisposition for breast and gynecologic cancers: recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer [2024]
• High-income countries
  • American Journal of Obstetrics & Gynecology
    • Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis [2023]
  • BMJ Open
    • Decision aids for female BRCA mutation carriers: a scoping review [2024]
• India
  • JCO Global Oncology
    • Genetic Counseling, Testing, and Management of HBOC in India: An Expert Consensus Document from Indian Society of Medical and Pediatric Oncology [2020]
• International
  • Breast Cancer Research and Treatment
    • An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers [2016]
  • European Journal of Cancer
    • Clinical practice guidelines for BRCA1 and BRCA2 genetic testing [2021]
  • Genetics in Medicine
    • The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome [2019]
  • Journal of Medical Economics
    • A review of the cost-effectiveness of genetic testing for germline variants in familial cancer [2023]
  • Journal of Oncology
    • Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in BRCA1/2: A Review of Secondary Prevention Guidelines [2020]
  • npj Genomic Medicine
    • Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices [2018]
• Israel
  • Israel Medical Association Journal
    • Variations in Practice and Geographic Disparities Between Dedicated Multidisciplinary Clinics for BRCA1/BRCA2 Mutation Carriers in Israel [2023]
• Japan
  • Journal of Gynecologic Oncology
    • Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO) [2022]
  • Scientific Reports
    • Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan [2023]
• North Africa
  • BMC Cancer
    • Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa [2022]
• Republic of Korea
  • Cancers
    • A Population-Based Analysis of BRCA1/2 Genes and Associated Breast and Ovarian Cancer Risk in Korean Patients: A Multicenter Cohort Study [2021]
  • Journal of Gynecologic Oncology
    • Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO) [2016]
• Singapore
  • Annals Academy of Medicine Singapore
    • Singapore Cancer Network (SCAN) Guidelines for Referral for Genetic Evaluation of Common Hereditary Cancer Syndromes [2015]
• Slovenia
  • BMC Cancer
    • Identification of women at risk for hereditary breast and ovarian cancer in a sample of 1000 Slovenian women: a comparison of guidelines [2021]
  • Scientific Reports
    • Assessment of pathogenic variation in gynecologic cancer genes in a national cohort [2023]
• South Asia
  • Journal of International Medical Research
    • BRCA1/ BRCA2 mutation spectrum analysis in South Asia: a systematic review [2022]
• Spain
  • Sociedad Española de Oncología Médica
    • SEOM clinical guidelines in hereditary breast and ovarian cancer (2019) [2020]
• Switzerland
  • European Journal of Health Economics
    • Cost-utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland [2022]
  • Swiss Medical Weekly
    • Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer [2021]
• United Kingdom
  • Association of Breast Surgery
    • Joint ABS-UKCGG-CanGene-CanVar consensus regarding the use of CanRisk in clinical practice [2024]
  • Health Technology Assessment
    • Gynaecological cancer surveillance for women with Lynch syndrome: systematic review and cost-effectiveness evaluation [2024]
  • Journal of Medical Genetics
    • UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2 [2023]
    • Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group [2018]
  • NHS England
    • Genetic Testing for BRCA1 and BRCA2 Mutations [2015]
• United States
  • Agency for Healthcare Research and Quality
    • Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer [2013]
  • American College of Medical Genetics and Genomics
    • Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) [2023]
    • A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment [2015]
  • American College of Obstetricians and Gynecologists
    • Hereditary Cancer Syndromes and Risk Assessment [2019]
    • Cascade Testing: Testing Women for Known Hereditary Genetic Mutations Associated With Cancer [2018]
  • American Society of Clinical Oncology
    • Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline [2024]
  • Cancer
    • BRCA testing in unaffected young women in the United States, 2006-2017 [2020]
  • Centers for Disease Control and Prevention
    • BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18–64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas — United States, 2009–2014 [2017]
    • Hereditary Breast and Ovarian Cancer
  • EBioMedicine
    • Prediction of Cancer Prevention: From Mammogram Screening to Identification of BRCA1/2 Mutation Carriers in Underserved Populations [2015]
  • Hereditary Cancer in Clinical Practice
    • Evaluation and comparison of hereditary Cancer guidelines in the population [2021]
  • JAMA Network Open
    • Cost-Effectiveness of Population-Based Multigene Testing for Breast and Ovarian Cancer Prevention [2024]
    • Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer [2024]
    • Trends in Positive BRCA Test Results Among Older Women in the United States, 2008-2018 [2020]
  • JNCCN
    • Nationwide Trends and Determinants of Germline BRCA1/2 Testing in Patients With Breast and Ovarian Cancer [2023]
  • National Cancer Institute
    • Genetics of Breast and Gynecologic Cancers (PDQ®)
  • National Comprehensive Cancer Network
    • NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024 [2023]
    • Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology [2021]
  • National Society of Genetic Counselors
    • Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes-Practice resource of the National Society of Genetic Counselors [2021]
  • Society of Gynecologic Oncology
    • Genetics Toolkit [2020]
    • Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review [2019]
    • Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper [2017]
    • Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions [2015]
  • U.S. Preventive Services Task Force
    • BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing [2024]
• {Related topics}
  • Topic
    • Gynecologic oncology
    • Familial breast cancer

Ovarian cancer

• Australia
  • Australian Journal of General Practice
    • Advances in epithelial ovarian cancer [2020]
• Canada
  • BC Cancer Agency
    • Ovary – Non-Epithelial Carcinoma
    • Ovary - Epithelial Carcinoma
  • Canadian Cancer Society
    • Ovarian cancer
  • CMAJ
    • Management of ovarian cancer risk in women with BRCA1/2 pathogenic variants [2019]
• Denmark
  • Gynecologic Oncology
    • Incidence, treatment, and survival trends in older versus younger women with epithelial ovarian cancer from 2005 to 2018: A nationwide Danish study [2022]
• Europe
  • European Society for Medical Oncology
    • ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease [2019]
    • Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2018]
    • Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2018]
  • European Society of Gynaecological Oncology
    • ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease [2024]
    • Non-Epithelial Ovarian Cancers in Adolescents and Young Adults [2019]
• France
  • Cancers
    • Multi-Disciplinary Care Planning of Ovarian Cancer in Older Patients: General Statement—A Position Paper from SOFOG-GINECO-FRANCOGYN-SFPO [2022]
  • Journal of Clinical Medicine
    • Results of a 2021 French National Survey on Management of Patients with Advanced Stage Epithelial Ovarian Cancer [2021]
• International
  • BMC Public Health
    • Enhancing ovarian cancer care: a systematic review of guideline adherence and clinical variation [2019]
  • Carcinogenesis
    • Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research [2021]
  • Gynecologic Cancer Intergroup
    • Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference [2017]
  • Journal of Ovarian Research
    • The clinical characteristics and treatment of ovarian malignant mesoderm mixed tumor: a systematic review [2022]
  • Nature Reviews Cancer
    • Rethinking Ovarian Cancer: Recommendations for Improving Outcomes [2011]
• Switzerland
  • Swiss Medical Weekly
    • Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data [2018]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Ovarian cancer (Quality standard) [2025]
    • Ovarian cancer: recognition and initial management [2023]
    • Ovarian cancer
  • Public Health Scotland
    • Ovarian cancer
  • Royal College of Obstetricians and Gynaecologists
    • Management of Female Malignant Ovarian Germ Cell Tumours [2016]
    • The Distal Fallopian Tube as the Origin of Non-uterine Pelvic High-grade Serous Carcinomas [2014]
    • Management of Ascites in Ovarian Cancer Patients [2014]
• United States
  • American Cancer Society
    • Ovarian Cancer
  • American Society of Clinical Oncology
    • Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline [2021]
  • Cancer
    • Improving the quality of care for patients with advanced epithelial ovarian cancer: Program components, implementation barriers, and recommendations [2022]
  • Centers for Disease Control and Prevention
    • Ovarian Cancer
  • Journal of Women's Health
    • Adherence of Primary Care Physicians to Evidence-Based Recommendations to Reduce Ovarian Cancer Mortality [2016]
  • M.D. Anderson Cancer Center
    • Ovarian Cancer
  • National Academies of Sciences, Engineering, and Medicine
    • Ovarian Cancers: Evolving Paradigms in Research and Care [2016]
  • Obstetrics & Gynecology
    • Health Disparities in Ovarian Cancer: Report From the Ovarian Cancer Evidence Review Conference [2023]
    • Executive Summary of the Ovarian Cancer Evidence Review Conference [2023]
  • OncoLink
    • Ovarian Cancer
  • StatPearls
    • Epithelial Ovarian Cancer
• {Related topics}
  • Topic
    • Ovarian cancer: treatment
    • Ovarian cancer: screening, prevention, diagnosis
    • Ovarian cancer: epidemiology
    • Gynecologic oncology

Ovarian cancer: epidemiology

• Brunei Darussalam
  • Asian Pacific Journal of Cancer Prevention
    • Incidence, Mortality and Survival Analysis of Epithelial Ovarian Cancer in Brunei Darussalam [2022]
• China
  • Frontiers in Public Health
    • Configurational analysis of ovarian cancer incidence in 30 provinces of China and its policy implications: a fuzzy-set qualitative comparative analysis approach [2024]
  • Journal of Ovarian Research
    • Trends in incidence and mortality for ovarian cancer in China from 1990 to 2019 and its forecasted levels in 30 years [2023]
• Europe
  • British Journal of Cancer
    • An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study [2015]
• Germany
  • Robert Koch Institute
    • Ovarian cancer
• Hong Kong
  • Acta Obstetricia et Gynecologica Scandinavica
    • Trends and projections of ovarian cancer incidence in Hong Kong: A population-based study [2023]
• Indonesia
  • PLoS ONE
    • Investigation of the trends and associated factors of ovarian cancer in Indonesia: A systematic analysis of the Global Burden of Disease study 1990-2021 [2025]
• International
  • BMC Cancer
    • Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis [2019]
  • Cancers
    • Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study [2022]
  • European Journal of Cancer Prevention
    • Global, regional, and national burden of ovarian cancer among young women during 1990-2019 [2024]
  • Frontiers in Public Health
    • Disease Burden and Attributable Risk Factors of Ovarian Cancer From 1990 to 2017: Findings From the Global Burden of Disease Study 2017 [2021]
  • International Journal of Cancer
    • The influence of birth cohort and calendar period on global trends in ovarian cancer incidence [2020]
  • International Journal of Women's Health
    • Ovarian cancer in the world: epidemiology and risk factors [2019]
  • Journal of Preventive Medicine and Hygiene
    • Worldwide incidence and mortality of ovarian cancer and Human Development Index (HDI): GLOBOCAN sources and methods 2018 [2021]
  • Journal of the National Cancer Institute
    • Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis [2023]
• Republic of Korea
  • Journal of Gynecologic Oncology
    • Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012 [2015]
  • Scientific Reports
    • Nationwide population-based study of prevalence and trend of borderline ovarian tumors in the Republic of Korea [2021]
• Singapore
  • Asian Pacific Journal of Cancer Prevention
    • Ovarian Cancer Incidence in the Multi-Ethnic Asian City-State of Singapore 1968-2012 [2019]
• South Africa
  • BMC Cancer
    • Trends in national and ethnic burden of ovarian cancer mortality in South Africa (1999-2018): a population based, age-period-cohort and join point regression analyses [2025]
• United Kingdom
  • Cancer Research UK
    • Ovarian cancer statistics
• United States
  • American Cancer Society
    • Ovarian Cancer Statistics
  • Cancer Epidemiology Biomarkers & Prevention
    • Population Distribution of Lifetime Risk of Ovarian Cancer in the United States [2015]
  • Cancer Research Communications
    • Trends of Ovarian Cancer Incidence by Histotype and Race/Ethnicity in the United States 1992-2019 [2023]
  • National Cancer Institute
    • Ovarian Cancer
• WHO
  • World Health Organization
    • Ovary cancer
• {Related topics}
  • Topic
    • Ovarian cancer

Ovarian cancer: screening, prevention, diagnosis

• Austria
  • Wiener klinische Wochenschrift
    • AGO Austria recommendations for genetic testing of patients with ovarian cancer [2015]
• Austria, Germany, Switzerland
  • Archives of Gynecology and Obstetrics
    • Intergroup-statement: statement of the german ovarian cancer commission, the North-Eastern German Society of gynecological Oncology (NOGGO), AGO Austria and AGO Swiss regarding the use of homologous repair deficiency (HRD) assays in advanced ovarian cancer [2025]
    • Intergroup statement: opportunistic salpingectomy-molecular pathology, clinical outcomes and implications for practice (German Ovarian Cancer Commission, the North-Eastern German Society of Gynecologic Oncology (NOGGO), AGO Austria and AGO Swiss) [2025]
• Belgium
  • Facts, Views & Vision in ObGyn
    • The rationale of opportunistic bilateral salpingectomies (OBS) during benign gynaecological and obstetric surgery: a consensus text of the Flemish Society of Obstetrics and Gynaecology (VVOG) [2019]
• Brazil
  • Revista da Associação Médica Brasileira
    • Relapsed ovarian cancer - diagnosis using 18F-FDG PET/CT [2019]
• Canada
  • Journal of Medical Genetics
    • Practice guidelines for BRCA1/2 tumour testing in ovarian cancer [2022]
• Denmark
  • International Journal of Cancer
    • Risk of nonovarian cancer in a nationwide-based study of nearly 5000 women with borderline ovarian tumors in Denmark [2023]
    • Pregnancy duration and ovarian cancer risk: A 50-year nationwide cohort study [2022]
• Europe
  • Annals of Oncology
    • European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer [2022]
  • European Menopause and Andropause Society
    • Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement [2017]
  • European Society of Gastrointestinal and Abdominal Radiology
    • Imaging of peritoneal metastases of ovarian and colorectal cancer: joint recommendations of ESGAR, ESUR, PSOGI, and EANM [2024]
  • European Society of Urogenital Radiology
    • ESR Essentials: characterisation and staging of adnexal masses with MRI and CT-practice recommendations by ESUR [2024]
  • International Journal of Gynecological Cancer
    • Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer [2016]
  • Seminars in Oncology
    • Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients [2017]
• Europe, United States
  • BJS Open
    • Ovarian cancer risk reduction by salpingectomy during non-gynaecological surgery: scoping review [2024]
  • Society of Abdominal Radiology
    • Ovarian cancer reporting lexicon for computed tomography (CT) and magnetic resonance (MR) imaging developed by the SAR Uterine and Ovarian Cancer Disease-Focused Panel and the ESUR Female Pelvic Imaging Working Group [2022]
• Germany
  • PLoS Medicine
    • Ovarian cancer prevention through opportunistic salpingectomy during abdominal surgeries: A cost-effectiveness modeling study [2025]
• Gulf Cooperation Council
  • BMC Cancer
    • Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region: the PREDICT study [2021]
• Hong Kong
  • Centre for Health Protection
    • Recommendations on Prevention and Screening for Ovarian Cancer For Health Professionals [2018]
• International
  • BMC Cancer
    • Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines [2019]
  • Cancer Reports
    • Anthropometric factors and the risk of ovarian cancer: A systematic review and meta-analysis [2022]
  • Carcinogenesis
    • Urinary biomarkers for the detection of ovarian cancer: a systematic review [2022]
    • Identification of biomarkers for the diagnosis and targets for therapy in patients with clear cell ovarian cancer: a systematic literature review [2022]
  • Cochrane Database of Systematic Reviews
    • Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women [2022]
  • Frontiers in Endocrinology
    • The risk of ovarian cancer in hormone replacement therapy users: a systematic review and meta-analysis [2024]
  • International Federation of Gynecology and Obstetrics
    • FIGO position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy [2024]
  • Lancet Oncology
    • Ovarian cancer and smoking: individual participant meta-analysis including 28114 women with ovarian cancer from 51 epidemiological studies [2012]
  • Virchows Archiv
    • Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria [2016]
• Ireland
  • Department of Health Ireland
    • Diagnosis and Staging of Patients with Ovarian Cancer
• Italy
  • Critical Reviews in Oncology/Hematology
    • Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives [2019]
• Japan
  • Cancer Science
    • Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancer [2023]
• Netherlands
  • Familial Cancer
    • Optimizing the detection of hereditary predisposition in women with epithelial ovarian cancer: nationwide implementation of the Tumor-First workflow [2024]
  • Fertility and Sterility
    • Incidence of ovarian cancer after bilateral salpingo-oophorectomy in women with histologically proven endometriosis [2022]
• New Zealand
  • Best Practice Advocacy Centre New Zealand
    • Ovarian cancer – early detection and referral [2023]
• Puerto Rico
  • BioMed Research International
    • Ovarian Cancer Screening Practices of Obstetricians and Gynecologists in Puerto Rico [2014]
• Republic of Korea
  • Cancer Medicine
    • Stratifying the risk of ovarian cancer incidence by histologic subtypes in the Korean Epithelial Ovarian Cancer Study (Ko-EVE) [2023]
  • Cancer Science
    • Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer [2021]
  • Scientific Reports
    • Increased risk of young-onset ovarian cancer in women with non-alcoholic fatty liver disease: A nationwide cohort study of 2.3 million women aged 20-39 years [2025]
• Spain
  • Sociedad Española de Oncología Médica
    • Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology [2018]
• Taiwan
  • BMC Women's Health
    • Association of pelvic inflammatory disease (PID) with ovarian cancer: a nationwide population-based retrospective cohort study from Taiwan [2021]
  • International Journal of Environmental Research and Public Health
    • Different Influences of Endometriosis and Pelvic Inflammatory Disease on the Occurrence of Ovarian Cancer [2021]
• United Kingdom
  • BJOG: An International Journal of Obstetrics & Gynaecology
    • The detection of germline and somatic BRCA1/2 genetic variants through parallel testing of patients with high-grade serous ovarian cancer: a national retrospective audit [2022]
  • BMC Medicine
    • Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation [2016]
  • Health Technology Assessment
    • Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial [2025]
    • Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis [2018]
  • Journal of Medical Genetics
    • The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2 [2023]
  • National Institute for Health and Care Excellence
    • Ovarian cancer: identifying and managing familial and genetic risk [2024]
    • Tests in secondary care to identify people at high risk of ovarian cancer [2017]
  • Royal College of Obstetricians and Gynaecologists
    • Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause [2021]
  • UK National Screening Committee
    • Ovarian cancer
• United States
  • Agency for Healthcare Research and Quality
    • Screening for Ovarian Cancer [2018]
  • American College of Obstetricians and Gynecologists
    • Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention [2019]
    • The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk [2017]
  • American College of Radiology
    • Staging and Follow-Up of Ovarian Cancer
    • Ovarian Cancer Screening
  • American Society of Clinical Oncology
    • Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline [2020]
  • BMJ Quality & Safety
    • When evidence says no: gynaecologists’ reasons for (not) recommending ineffective ovarian cancer screening [2020]
  • Clinical Journal of Oncology Nursing
    • Ovarian Cancer Symptom Clusters: Use of the NIH Symptom Science Model for Precision in Symptom Recognition and Management [2022]
  • Environmental Health Perspectives
    • Outdoor Air Pollution Exposure and Ovarian Cancer Incidence in a United States-Wide Prospective Cohort Study [2024]
  • International Journal of Gynecological Cancer
    • Temporal trends of healthcare system use between symptomatic presentation and ovarian cancer diagnosis in the United States [2022]
  • JCO Oncology Practice
    • Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes [2022]
  • Society of Gynecologic Oncology
    • Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer [2015]
    • SGO Clinical Practice Statement: Genetic Testing for Ovarian Cancer [2014]
    • SGO Clinical Practice Statement: Salpingectomy for Ovarian Cancer Prevention [2013]
  • U.S. Preventive Services Task Force
    • Ovarian Cancer: Screening [2018]
• {Related topics}
  • Topic
    • Ovarian cancer

Ovarian cancer: treatment

• Asia
  • BMC Cancer
    • Survival rate of ovarian cancer in Asian countries: a systematic review and meta-analysis [2023]
• Austria
  • Wiener klinische Wochenschrift
    • Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer [2022]
• Belgium
  • PLoS ONE
    • First- and second-line bevacizumab in ovarian cancer: A Belgian cost-utility analysis [2018]
• Canada
  • Canadian Agency for Drugs and Technologies in Health
    • Bevacizumab for Recurrent Platinum-Sensitive Ovarian Cancer [2023]
  • Current Oncology
    • Systemic therapy for recurrent epithelial ovarian cancer: a clinical practice guideline [2017]
  • Gynecologic Oncology
    • Spatial Analysis of Adherence to Treatment Guidelines for Advanced-Stage Ovarian Cancer and the Impact of Race and Socioeconomic Status [2014]
  • Ontario Health
    • Homologous Recombination Deficiency Testing to Inform Patient Decisions About Niraparib Maintenance Therapy for High-Grade Serous or Endometrioid Epithelial Ovarian Cancer: A Health Technology Assessment [2023]
    • Adjuvant Care for Stage I Ovarian Cancer [2022]
    • Systemic Therapy for Recurrent Epithelial Ovarian Cancer [2017]
• Colombia
  • Revista Colombiana de Obstetricia y Ginecología
    • Expert consensus: Profiling and management of advanced or metastatic epithelial ovarian cancer [2024]
• Denmark
  • Journal of Geriatric Oncology
    • Impact of surgery and chemotherapy timing on outcomes in older versus younger epithelial ovarian cancer patients: A nationwide Danish cohort study [2023]
• Europe
  • European Society for Medical Oncology
    • eUpdate – Newly Diagnosed Epithelial Ovarian Carcinoma Treatment Recommendations [2021]
    • ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer [2020]
  • European Society of Gynaecological Oncology
    • Ovarian cancer surgery [2017]
    • ESGO Advanced (stage III-IV) Ovarian Cancer Surgery Quality Indicators [2016]
• France
  • Annals of Surgical Oncology
    • Status of Surgical Management of Borderline Ovarian Tumors in France: are Recommendations Being Followed? Multicentric French Study by the FRANCOGYN Group [2021]
  • Gynecologic Oncology
    • Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort [2022]
• Germany
  • Institute for Quality and Efficiency in Health Care
    • Rucaparib (ovarian cancer; maintenance treatment) - Benefit assessment according to §35a Social Code Book V [2019]
  • Women's Health
    • Ovarian cancer surgery in Germany: An analysis of the nationwide hospital file 2005-2015 [2022]
• International
  • American Journal of Therapeutics
    • Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis [2023]
  • Clinical Cancer Research
    • Small Cell Carcinoma of the Ovary, Hypercalcaemic Type – genetics, new treatment targets and current management guidelines [2020]
  • Cochrane Database of Systematic Reviews
    • Angiogenesis inhibitors for the treatment of epithelial ovarian cancer [2023]
    • Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer [2022]
    • Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery [2022]
  • European Society of Gynaecological Oncology
    • ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors [2021]
  • Gynecologic Cancer Intergroup
    • Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup [2022]
    • Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysis [2021]
    • Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer [2020]
    • Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference [2017]
    • Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease [2017]
    • Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions [2017]
    • Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumours [2017]
    • Survivorship as an element of clinical trials in ovarian cancer [2011]
    • 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004) [2005]
  • International Journal of Gynecological Cancer
    • Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care [2020]
  • International Journal of Hyperthermia
    • Prognostic value and adverse events of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in primary advanced and platinum-sensitive recurrent epithelial ovarian cancer: a systematic review and meta-analysis [2023]
  • Journal of Gynecologic Oncology
    • Factors predicting postoperative morbidity after cytoreductive surgery for ovarian cancer: a systematic review and meta-analysis [2022]
  • Medicine
    • Reproductive and oncological outcomes of fertility-sparing surgery in patients with stage I epithelial ovarian cancer: A systematic review and meta-analysis [2022]
  • World Journal of Surgical Oncology
    • Outcome quality standards in advanced ovarian cancer surgery [2020]
• Italy
  • Current Oncology
    • The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach [2024]
  • Journal of Gynecologic Oncology
    • Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups [2022]
  • Journal of Ovarian Research
    • Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status [2019]
• Netherlands
  • Acta Obstetricia et Gynecologica Scandinavica
    • Stage, treatment and survival of low-grade serous ovarian carcinoma in the Netherlands: A nationwide study [2023]
    • Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population-based cohort study [2022]
  • Gynecologic Oncology
    • Textbook outcome as a composite outcome measure to compare hospital performances regarding cytoreductive surgery for ovarian cancer: A nationwide population-based study [2023]
  • Gynecologic Oncology Reports
    • Standardizing HIPEC and perioperative care for patients with ovarian cancer in the Netherlands using a Delphi-based consensus [2022]
• Republic of Korea
  • ClinicoEconomics and Outcomes Research
    • Cost–utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model [2013]
  • Journal of Gynecologic Oncology
    • Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines [2025]
    • Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines [2024]
    • Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study [2022]
    • Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement [2018]
• Singapore
  • Annals Academy of Medicine Singapore
    • Singapore Cancer Network (SCAN) Guidelines for Front-Line Systemic Therapy of Newly Diagnosed Advanced Epithelial Ovarian Cancer [2015]
• Spain
  • Clinical and Translational Oncology
    • GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012 [2013]
  • Journal of Ovarian Research
    • Management of advanced ovarian cancer in Spain: an expert Delphi consensus [2021]
  • Sociedad Española de Oncología Médica
    • SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023) [2024]
    • SEOM clinical guideline in ovarian cancer (2020) [2021]
  • Virchows Archiv
    • Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH) [2020]
• Sri Lanka
  • Sri Lanka College of Obstetricians & Gynaecologists
    • Management of epithelial ovarian cancers [2021]
• Sweden
  • Gynecologic Oncology
    • Hormone replacement in premenopausal women treated with bilateral oophorectomy for ovarian cancer - a nationwide population-based study [2022]
• United Kingdom
  • British Gynaecological Cancer Society
    • British Gynaecological Cancer Society Recommendations for Evidence Based, Population Data Derived Quality Performance Indicators for Ovarian Cancer [2023]
  • National Institute for Health and Care Excellence
    • Maximal cytoreductive surgery for advanced ovarian cancer [2023]
    • Bevacizumab with carboplatin, gemcitabine and paclitaxel for treating the first recurrence of platinum-sensitive advanced ovarian cancer (terminated appraisal) [2019]
    • Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer [2016]
    • Ovarian cancer (advanced): bevacizumab 7.5 mg/kg in combination with paclitaxel and carboplatin for first-line treatment [2013]
    • Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer [2013]
    • Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer [2013]
  • NHS England
    • Clinical commissioning policy: Trametinib in recurrent or progressive low grade serous ovarian cancer (adults) [2023]
  • Royal College of Obstetricians and Gynaecologists
    • The Use of Biomarkers to Stratify Surgical Care in Women with Ovarian Cancer [2022]
    • Targeted therapies for the management of ovarian cancer [2013]
• United States
  • American Society of Clinical Oncology
    • Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update [2025]
    • Poly(ADP-Ribose) Polymerase Inhibitors in the Management of Ovarian Cancer: ASCO Guideline Rapid Recommendation Update [2022]
    • PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline [2020]
  • Annals of Surgical Oncology
    • Is it time to centralize ovarian cancer care in the United States? [2016]
  • Cancer
    • The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms [2020]
  • Food and Drug Administration
    • FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRa-Positive, Platinum-Resistant Ovarian Cancer [2023]
    • FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy [2015]
  • Gynecologic Oncology
    • Trends in estimated PARP inhibitor eligibility and benefit among US epithelial ovarian cancer patients [2024]
    • Racial disparities in non-recommendation of adjuvant chemotherapy in stage II-III ovarian cancer [2022]
    • Ovarian cancer in the United States: Contemporary patterns of care associated with improved survival [2014]
  • Institute for Clinical and Economic Review
    • Ovarian Cancer
  • International Journal of Gynecological Cancer
    • National trends in bowel and upper abdominal procedures in ovarian cancer surgery [2020]
  • JAMA Network Open
    • Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016 [2020]
  • Journal of the National Cancer Institute
    • Disparities in Ovarian Cancer Care Quality and Survival According to Race and Socioeconomic Status [2013]
  • National Cancer Institute
    • State of the Biomarker Science in Ovarian Cancer: A National Cancer Institute Clinical Trials Planning Meeting Report [2022]
    • Ovarian Germ Cell Tumors Treatment (PDQ®)
    • Ovarian Borderline Tumors Treatment (PDQ®)
    • Childhood Ovarian Cancer Treatment (PDQ®)
  • National Comprehensive Cancer Network
    • NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022 [2022]
    • Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology [2021]
  • Obstetrics & Gynecology
    • Trends in Relative Survival for Ovarian Cancer From 1975 to 2011 [2015]
    • Racial Disparities in the Treatment of Advanced Epithelial Ovarian Cancer [2013]
  • PLoS ONE
    • Trends in extent of surgical cytoreduction for patients with ovarian cancer [2021]
  • Society of Gynecologic Oncology
    • Society of Gynecologic Oncology Journal Club: Controversial conversations in gynecologic cancer - Navigating maintenance therapy for homologous recombinant proficient ovarian cancer [2022]
    • FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper [2017]
    • Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline [2016]
    • SGO guidance document for clinical trial designs in ovarian cancer: A changing paradigm [2014]
    • Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper [2014]
• {Related topics}
  • Topic
    • Ovarian cancer

Tubal cancer

• Canada
  • BC Cancer Agency
    • Fallopian Tube
  • Canadian Cancer Society
    • Fallopian tube cancer
• Germany
  • Archives of Gynecology and Obstetrics
    • A questionnaire-based survey on the diagnostic and therapeutic approaches for patients with STIC in Germany [2023]
• International
  • Virchows Archiv
    • Recommendations for diagnosing STIC: a systematic review and meta-analysis [2022]
• Taiwan
  • Taiwanese Journal of Obstetrics and Gynecology
    • Primary fallopian tube cancer: Domestic data and up-to-date review [2014]
• United States
  • Journal of the National Cancer Institute
    • Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer Registries [2018]
  • M.D. Anderson Cancer Center
    • Fallopian Tube Cancer
  • OncoLink
    • Fallopian Tube Cancer
• {Related topics}
  • Topic
    • Gynecologic oncology

Uterine sarcoma

• Austria, Germany, Switzerland
  • Geburtshilfe und Frauenheilkunde
    • Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021) [2022]
• Canada
  • Alberta Health Services
    • Uterine Sarcoma
  • BC Cancer Agency
    • Gynecological Sarcoma
  • Current Oncology
    • Chemotherapy (gemcitabine, docetaxel plus gemcitabine, doxorubicin, or trabectedin) in inoperable, locally advanced, recurrent, or metastatic uterine leiomyosarcoma: a clinical practice guideline [2013]
  • Ontario Health
    • Guidance for the Management of Gynecologic Sarcomas in Ontario: Recommendations Report [2024]
• Germany
  • Langenbeck's Archives of Surgery
    • Ten recommendations for sarcoma surgery: consensus of the surgical societies based on the German S3 guideline "Adult Soft Tissue Sarcomas" [2023]
• International
  • European Society of Gynaecological Oncology
    • ESGO/EURACAN/GCIG guidelines for the management of patients with uterine sarcomas [2024]
  • International Collaboration on Cancer Reporting
    • Data Set for Reporting of Uterine Malignant and Potentially Malignant Mesenchymal Tumors: Recommendations From the International Collaboration on Cancer Reporting (ICCR) [2022]
    • Uterine Malignant and Potentially Malignant Mesenchymal Tumours
  • International Federation of Gynecology and Obstetrics
    • Uterine sarcomas [2018]
  • Medicina
    • Is Adnexectomy Mandatory at the Time of Hysterectomy for Uterine Sarcomas? A Systematic Review and Meta-Analysis [2022]
• Republic of Korea
  • Journal of Gynecologic Oncology
    • Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National Cancer Registry study [2023]
• Spain
  • Sociedad Española de Oncología Médica
    • SEOM-GEIS Spanish clinical guidelines for the management of soft-tissue sarcomas (2024) [2025]
    • SEOM Clinical Guideline of management of soft-tissue sarcoma (2020) [2021]
  • Therapeutic Advances in Medical Oncology
    • Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS) [2023]
• Taiwan
  • Taiwanese Journal of Obstetrics and Gynecology
    • Uterine sarcoma Part I—Uterine leiomyosarcoma: The Topic Advisory Group systematic review [2016]
    • Uterine sarcoma Part II—Uterine endometrial stromal sarcoma: The TAG systematic review [2016]
    • Uterine sarcoma Part III—Targeted therapy: The Taiwan Association of Gynecology (TAG) systematic review [2016]
• United Kingdom
  • British Journal of Cancer
    • UK guidelines for the management of soft tissue sarcomas [2025]
  • Clinical Sarcoma Research
    • UK guidelines for the management of soft tissue sarcomas [2016]
  • Royal College of Pathologists
    • Dataset for histopathological reporting of uterine sarcomas [2018]
• United States
  • American Cancer Society
    • Uterine Sarcoma
  • Journal of Gynecologic Oncology
    • Trends of uterine carcinosarcoma in the United States [2018]
  • National Cancer Institute
    • Uterine Sarcoma Treatment (PDQ®)
  • National Comprehensive Cancer Network
    • Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN Guidelines [2015]
• {Related topics}
  • Topic
    • Gynecologic oncology

Vaginal cancer

• Canada
  • BC Cancer Agency
    • Vagina
  • Canadian Cancer Society
    • Vaginal cancer
• Denmark
  • Gynecologic Oncology
    • Vaginal melanoma in Denmark from 1980 to 2018: A population-based study based on genetic profile and survival [2022]
• Europe
  • European Society for Radiotherapy and Oncology
    • ESTRO/ESGO/SIOPe guidelines for the management of patients with vaginal cancer [2023]
• Finland
  • Preventive Medicine
    • Lower incidence of vaginal cancer after cervical human papillomavirus screening - long-term follow-up of Finnish randomized screening trial [2024]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018) [2019]
• International
  • Current Oncology
    • Innovations in the Management of Vaginal Cancer [2022]
  • European Society of Gynaecological Oncology
    • The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia [2023]
  • International Collaboration on Cancer Reporting
    • Data Set for the Reporting of Carcinomas of the Vagina: Recommendations From the International Collaboration on Cancer Reporting (ICCR) [2022]
    • Carcinomas of the Vagina
  • International Federation of Gynecology and Obstetrics
    • Cancer of the vagina: 2021 update [2021]
    • Cancer of the vagina [2018]
• New Zealand
  • Best Practice Advocacy Centre New Zealand
    • Vaginal cancer – early detection and referral [2023]
• United Kingdom
  • Cancer Research UK
    • Vaginal cancer statistics
• United States
  • American Cancer Society
    • Vaginal Cancer
  • American College of Radiology
    • Staging and Follow-up of Primary Vaginal Cancer
  • M.D. Anderson Cancer Center
    • Vaginal Cancer
  • National Cancer Institute
    • Vaginal Cancer Treatment (PDQ®)
  • OncoLink
    • Vaginal Cancer
• {Related topics}
  • Topic
    • Gynecologic oncology

Vulvar cancer

• Australasia
  • Royal College of Pathologists of Australasia
    • Vulva
• Canada
  • BC Cancer Agency
    • Vulva
  • Canadian Cancer Society
    • Vulvar cancer
  • Ontario Health
    • Sentinel Lymph Node Biopsy in Vulvar Cancer [2018]
  • Society of Obstetricians and Gynaecologists of Canada
    • Management of Squamous Cell Cancer of the Vulva [2019]
• Croatia
  • Croatian Medical Journal
    • Epidemiology of vulvar cancer in Croatia [2023]
• Denmark
  • Gynecologic Oncology
    • Preoperative predictors of inguinal lymph node metastases in vulvar cancer - A nationwide study [2022]
• Europe
  • European Society of Gynaecological Oncology
    • European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023 [2023]
    • Vulvar cancer [2016]
  • European Society of Urogenital Radiology
    • Vulvar cancer staging: guidelines of the European Society of Urogenital Radiology (ESUR) [2021]
  • Ultrasound in Obstetrics & Gynecology
    • Terms, definitions and measurements to describe sonographic features of lymph nodes: consensus opinion from the Vulvar International Tumor Analysis (VITA) group [2021]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015 [2016]
  • PLoS ONE
    • Incidence Patterns and Temporal Trends of Invasive Nonmelanotic Vulvar Tumors in Germany 1999-2011. A Population-Based Cancer Registry Analysis [2015]
  • Robert Koch Institute
    • Cancer of the vulva
• India
  • JCO Global Oncology
    • The Unmet Needs in the Management of Vulvar Cancer and a Review of Indian Literature [2022]
• International
  • Cancers
    • New Insights into the Epidemiology of Vulvar Cancer: Systematic Literature Review for an Update of Incidence and Risk Factors [2022]
    • How Can We Treat Vulvar Carcinoma in Pregnancy? A Systematic Review of the Literature [2021]
  • European Society of Gynaecological Oncology
    • Vulvar inspection at the time of cervical cancer screening: European Society of Gynaecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European Federation for Colposcopy (EFC) consensus statements [2025]
    • The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions [2022]
  • International Collaboration on Cancer Reporting
    • Data Set for the Reporting of Carcinomas of the Vulva: Recommendations From the International Collaboration on Cancer Reporting (ICCR) [2022]
    • Carcinomas of the Vulva
  • International Federation of Gynecology and Obstetrics
    • Cancer of the vulva: 2021 update [2021]
    • Cancer of the vulva [2018]
  • International Journal of Gynecological Pathology
    • Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer [2020]
  • International Society for the Study of Vulvovaginal Disease
    • Diagnostic Criteria for Differentiated Vulvar Intraepithelial Neoplasia and Vulvar Aberrant Maturation [2021]
  • PLoS ONE
    • Prevalence of human papillomavirus and its prognostic value in vulvar cancer: A systematic review and meta-analysis [2018]
• Italy
  • Journal of Cancer Research and Clinical Oncology
    • Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT [2020]
• Netherlands
  • International Journal of Cancer
    • Vulvar intraepithelial neoplasia: Incidence and long-term risk of vulvar squamous cell carcinoma [2021]
• New Zealand
  • Best Practice Advocacy Centre New Zealand
    • Vulval cancer – early detection and referral [2023]
• Poland
  • Ginekologia Polska
    • Analysis of incidence and overall survival of patients with vulvar cancer in Poland in 2008–2016 — implications for cancer registries [2022]
• Republic of Korea
  • Journal of Korean Medical Science
    • Prevalence and Treatment of Vulvar Cancer From 2014-2018: A Nationwide Population-Based Study in Korea [2022]
• Sri Lanka
  • Sri Lanka College of Obstetricians & Gynaecologists
    • Management of vulval cancer [2021]
• United Kingdom
  • British Gynaecological Cancer Society
    • British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: An update on recommendations for practice 2023 [2024]
  • Cancer Research UK
    • Vulval cancer statistics
  • Royal College of Pathologists
    • Dataset for histopathological reporting of vulval carcinomas [2023]
  • Royal College of Radiologists
    • The Royal College of Radiologists expert panel recommendations for radiotherapy treatment for vulval cancer [2024]
• United States
  • American Cancer Society
    • Vulvar Cancer
  • American College of Obstetricians and Gynecologists
    • Management of Vulvar Intraepithelial Neoplasia [2016]
  • American College of Radiology
    • Staging and Follow-up of Vulvar Cancer
    • Adjuvant Therapy in Vulvar Cancer
  • Cancer Reports
    • Incidence Trends of Vulvar Cancer in the United States: A 20-Year Population-Based Study [2024]
  • M.D. Anderson Cancer Center
    • Vulvar Cancer
  • National Cancer Institute
    • Vulvar Cancer Treatment (PDQ®)
    • Vulvar Cancer
  • National Comprehensive Cancer Network
    • Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology [2024]
    • Vulvar Cancer
  • OncoLink
    • Vulvar Cancer
  • Society of Gynecologic Oncology
    • Vulvar cancer management and wrangling recurrent disease: A report from the society of gynecologic oncology journal club [2023]
• {Related topics}
  • Topic
    • Vulvar diseases
    • Gynecologic oncology